Skip to main content
Springer logoLink to Springer
. 2025 Jun 6;477(9):1135–1162. doi: 10.1007/s00424-025-03096-2

The machinery of healthy vasodilatation: an overview

Jana Pourová 1,, Patrícia Dias 2,3, Milan Pour 4, Přemysl Mladěnka 1
PMCID: PMC12420752  PMID: 40473983

Abstract

Cardiovascular function depends on an adequate vascular tone facilitating appropriate blood flow to individual tissues according to their needs. The tone results from the interplay between vasodilatation and vasoconstriction. Its rapid and efficient regulation is secured by many interconnected physiological mechanisms, both at the level of the vascular smooth muscle and the endothelium. The purpose of this review is to provide an update of the current knowledge on the mechanisms of physiological vasodilatation. First, two principal intracellular signaling pathways linked to the activation of protein kinases PKA and PKG are introduced. Subsequently, the role of endothelium-derived relaxing factors together with the endothelium-dependent hyperpolarization is discussed. The roles of ion channels and gap junctions in the communication between endothelium and vascular smooth muscle cells are particularly discussed. Finally, principal vasodilatory stimuli (mechanical, thermal, chemical) and their mechanisms of action are briefly introduced.

Keywords: Vasodilatation, PKA, PKG, NO, EDRF

Introduction

The cardiovascular system ensures the transport of blood and the substances dissolved throughout the body. The blood vessels form a vast network, extending to all tissues. This network is not homogeneous; individual vessels differ from each other not only in their diameters but also in their functions and properties. By way of example, the large arteries located close to the heart and distributing the blood pumped are primarily exposed to high pressure and convert the pulsatile blood flow into continuous blood flow. The small vessels play a crucial role in determining the vascular resistance (generally, 60–80% of resistance occurs in the microvasculature), and in regulating the blood flow to individual tissues, thereby significantly contributing to the regulation of the blood pressure. The capillaries secure the exchange of substances between blood and interstitial fluid, and the capacitance vessels control blood return to the heart and function as a reservoir of blood. According to their function, the blood vessels differ, for example, in the elasticity or in the amount of smooth muscle. The basic structure of the vessel wall however remains the same: the endothelium is a single layer of endothelial cells in direct contact with the blood. This is followed by the vascular smooth muscle (VSM) cells and elastic fibers. The outer layer contains fibroblasts, nerve endings, and adipocytes (perivascular adipose tissue, PVAT). The blood capillaries are formed only by the endothelial cells, basal membrane, and the pericytes. The pericytes regulate microvascular tone among other functions (for reviews, see [40, 137, 248]). In brain, the pericytes reflect neuronal activity in the vicinity, and participate in capillary dilatation which can spread back to upstream arterioles (neurovascular coupling). This signaling is complex, and includes the K+-mediated hyperpolarization (see Sect. Endothelium-dependent hyperpolarization). The abnormal contractility of pericytes is likely related to the progression of many diseases [232].

The vascular system can respond to immediate needs and regulate the flow of blood through individual tissues. A rapid and adequate vasodilatation or vasoconstriction in individual parts of the vasculature constitute the principal way of blood flow regulation. The VSM plays a crucial role in both processes. Unlike other smooth muscles, this one is significantly influenced by the adjacent endothelium. In general, both the VSM cells and the endothelial cells are influenced by the changes in membrane potential and pH, and by the mechanical, thermal and chemical stimuli. The latter mentioned include both endogenous and exogenous substances.

This review is focused on the mechanism of vasodilatation and attempts to describe its most important components. Other excellent reviews addressing particular aspects of vascular physiology have been published [48, 103, 134, 137, 155, 188, 230]. The aim of this paper is to provide a summary of the machinery of healthy vasodilatation, addressing its principal components and pathways in a comprehensive way. First, an overview of the physiological interplay of ion channels and ATPases in the VSM will be provided. Next, the principal vasodilatory cascades, the Ca2+ sparks, and the role of the endothelium will be described. In the last section, the principal mechanisms of action of the vasodilatory stimuli will be briefly addressed.

Interplay of ion channels and ATPases in the vascular smooth muscle

At the resting membrane potential (roughly − 35–60 mV in vivo, depends on location), there is a low basal movement of ions across the plasma membrane of the VSM cells. The probability of opening of the voltage-gated Kv, Cav, and Nav channels is low, thus allowing only mild ion flows. The same is true for Kir channels which are also voltage-gated. In general, the closure of the K+ channels causes depolarization. The closure can be initiated, e.g., by GPCR agonists on Gq receptors. The depolarization opens the voltage-gated Nav and Cav channels at the plasma membrane, and, in turn, the influx of these ions is initiated. The quick Na+ influx increases the activity of the Na+/H+ exchanger, which further promotes Na+ entry, depolarization, and alkalinization. Certain transient receptor potential (TRP) channels are weakly voltage-sensitive [167, 203, 237] and extracellular Ca2+ and Na+ ions can also enter through them. The Ca2+ ions from the intracellular stores flow into the cytoplasm as well, mainly from the sarcoplasmic reticulum (SR). A global increase in cytosolic calcium concentration ([Ca2+]c) sets the muscle contraction machinery in motion. The calcium-gated channels are opened as a consequence of the increased concentration of Ca2+ in their vicinity. The ClCa and TRPM4/5 channels contribute to further depolarization. In contrast, the KCa channels (in VSM the big conductance calcium-activated K+, BKCa channels) efflux K+ ions which results in the shift of the membrane potential towards the resting values (repolarization). Repolarization closes the voltage-gated channels at the plasma membrane (transition to the long-term inactivated state occurs within milliseconds following membrane depolarization). The Na+/K+ ATPase secures the efflux of Na+ ions from the cell along with the entry of K+ ions. If the membrane potential becomes more negative than the resting potential, the Kir channels open and with a mild K+ efflux intensify the membrane hyperpolarization until the equilibrium potential of K+ is achieved. The [Ca2+]c in VSM is reduced to the resting values by the action of the plasma membrane calcium ATPase (PMCA) and Na+/Ca2+ exchanger (NCX) on the plasma membrane and of the intracellular sarco/endoplasmic reticulum calcium ATPase (SERCA). For review, see [101, 102]. This machinery is supported by the frequent colocalization of the collaborating components; e.g., the vascular BKCa channels are in the proximity of the Ca2+ sources such as the Cav3.2 [88, 89], TRPV4 [52] and TRPC1 [123] channels. This region is referred to as a Ca2+ microdomain and is crucial for the Ca2+ signaling in VSM cells (for review, see [215]).

Vascular smooth muscle in vasodilatation

Vasodilatation involves the relaxation of the smooth muscle in the vascular wall. An increase in the blood flow through the pertinent area is its main consequence. Adequate vasodilatation is an important part of the body homeostasis because it ensures the blood supply and prevents oxygen and nutrient deprivation. In contrast, too extensive vasodilatation may result in a decrease in the systemic vascular resistance and a decrease in the blood pressure. The latter may trigger a reflex response involving, for example, an increase in the heart rate.

Both vasodilatation and vasoconstriction are always active. The resultant vascular tone depends on their extent and the interplay between them at each moment. Imbalance in one or in both can lead to a dysfunction or even contribute to (or cause) a disease. Briefly, the vasoconstriction is terminated by the breakdown of the actin-myosin complex, in which the dephosphorylation of the myosin light chain (MLC) on the MLC20 subunit with the participation of the myosin light chain phosphatase (MLCP) plays a key role. Vasodilatation is accompanied by a decrease in the level of calcium in the cytoplasm, due to the efflux of these ions out of the cell or due to the transfer to the SR. As mentioned, the former is mediated by the PMCA and the NCX exchanger, the latter by the intracellular ATPase SERCA. An adequate and fast vasodilatation at the site of need is secured in several ways. At the intracellular level, there are two important vasodilatory cascades associated with the activation of protein kinases A and G. Even though vasodilatation physiologically predominates over vasoconstriction, its magnitude and duration always have to be in line with the acute needs of the particular tissue. Analogously to vasoconstriction, the extent of vasodilatation is regulated by a negative feedback ensuring appropriate scope and transient duration of the response.

The following text will deal with two principal intracellular vasodilating signaling pathways, designated according to their main components: protein kinases A and G. Subsequently, the Ca2+ sparks protecting small resistance arteries against excessive pressure will be discussed.

Protein kinase A

Protein kinase A (PKA, syn. cAMP-dependent protein kinase) is an important cytoplasmic serine/threonine kinase. This protein is a tetramer composed of two regulatory (RI or RII) and two catalytic (Cα or Cβ) subunits. The PKA-1 and PKA-2 subtypes are distinguished by the R subunits. The PKA is the major intracellular receptor for cAMP, which regulates many important processes in this way. The A-kinase anchoring proteins (AKAPs) bind the R subunit (preferably RII over RI) and anchor the PKA to the plasma membrane. Simultaneously, they bind other components of this pathway, in particular adenylate cyclase and phosphodiesterase [74]. Also notably, the AKAPs bind other factors associated with vasoconstriction or vasodilatation, including PKC [195].

PKA activation

The PKA is activated by cAMP, which is produced by adenylate cyclase (AC). This membrane-bound enzyme is activated mainly by the extracellular vasodilatory substances that bind to their GPCR of the Gs-type on the plasma membrane. This binding gives rise to the dissociation of the α subunit in the form of Gs-GTP with the stimulation of AC and formation of cAMP. The Gs-GTP activity is terminated by the hydrolysis of GTP to GDP through the intrinsic GTPase activity of Gs; this process is regulated by GTPase-accelerating protein (GAP). The amount of the vascular cAMP is governed by phosphodiesterases (PDE), mainly by the PDE3 isoform. The AC can also be activated directly, e.g., by forskolin.

The cAMP causes the dissociation of the catalytic C subunits from PKA. The subunits subsequently phosphorylate the target molecules. This effect is regulated by the amount of the regulatory R subunits. The higher the R:C ratio, the faster the C subunits rebind to the R–C complex [74]. The formation of the R–C complex is promoted by the presence of ATP [139]; consequently, activation of PKA is reduced and vasodilatation counteracted. Simultaneously, ATP inactivates the KATP channels which promotes the membrane depolarization [117, 189]. The dissociation of the R–C complex is prevented by Ca2+ ions, whereas Mg2+ ions have the opposite effect. In this context, it is worth mentioning that the PKA anchored by the AKAPs is located close to the Cav channels [115].

The cAMP acts not only through PKA. The intracellular sensor of cAMP serves as the exchange factor directly activated by cAMP (EPAC). This protein is a Ras-like GTPase that may regulate the activity of Ras homolog family member A (RhoA), the KATP, and the ryanodine receptor operated (RyR) channels (and thus indirectly also the activity of the Ca2+-operated channels through Ca2+ levels). The effects of EPAC vary in different vessels: in the microvascular VSM cells, it stimulates RhoA and counteracts vasodilatation. The opposite seems to be true in larger arteries [130, 157].

Effects of activated PKA

Once activated, the PKA phosphorylates several targets. In general, it is associated with a decrease in the plasma membrane potential (more negative, repolarization), decrease in [Ca2+]c, dephosphorylation of MLC, and vasodilatation. At the plasma membrane, active PKA (1) increases K+ ion efflux through the BKCa, Kv, and KATP channels. The latter channels probably open when the resting membrane potential is reached [216]; (2) decreases [Ca2+]c by the inhibition of the inositol 1,4,5-trisphosphate receptor operated (IP3R) channels and by the activation of SERCA on the SR. The latter is mediated by the phosphorylation of the regulatory protein phospholamban, which is cleaved off [36]; (3) decreases the affinity of MLCK to the Ca2+-calmodulin complex (Ca2+-CaM) and thus its ability to phosphorylate MLC [38]; and (4) accelerates the hydrolysis of the active RhoA-GTP to inactive RhoA-GDP [163]. In addition, active PKA stabilizes the guanine nucleotide dissociation inhibitor-RhoA (GDI-RhoA) complex by the phosphorylation of GDI and thus prevents the activation of the RhoA/Rho-associated protein kinase (ROCK) cascade [20, 135, 185]. In the smooth muscle of the gastrointestinal tract, the PKA together with PKG reduce the production of diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) by the phosphorylation of PLCβ3 [165]. Similar effect might occur in the VSM, but no evidence has been reported. A question arises as to whether the PKA directly influences the MLCP. So far, only an indirect effect via the inhibition of RhoA/ROCK has been demonstrated in coronary arteries [256].

The PKA feedback

When activated, the PKA exhibits effects that limit its vasodilatory actions described above. It increases [Ca2+]c by the activation of (1) the membrane Cav channels and (2) of the RyR channels on the SR; and (3) weakly activates the MLC20 and stimulates Mg2+-ATPase activity of myosin independently of [Ca2+]c. This action is potentiated by the presence of arachidonic acid (at μM levels), which inactivates the MLCP both directly [75] and via ROCK. However, arachidonic acid itself does not influence MLCK [251]. It is the metabolites of arachidonic acid that may participate in its effects. It is notable that, surprisingly, the cAMP (principal activator of PKA) promotes the amplification of Ca2+ efflux from the SR (calcium-induced calcium release, CICR) [193].

The role of PKA is summarized in Figs. 1 and 2.

Fig. 1.

Fig. 1

The role of protein kinase A (PKA) in the vascular smooth muscle (VSM) cell relaxation. Binding of an agonist to the G protein-coupled receptor of the Gs type (GsPCR) causes the activation of adenylate cyclase (AC), an enzyme that produces cAMP from ATP. The former, in turn, activates PKA. The levels of cAMP are regulated by the action of phosphodiesterases (PDEs) (in the vascular smooth muscle, PDE3 is the main isoform). AC can also be activated directly, e.g., by forskolin. ATP gives rise to the inactivation of the ATP-dependent K+ (KATP) channels, which are important in the maintenance of the resting potential. cAMP promotes the amplification of Ca2+ efflux from the SR (i.e., calcium-induced calcium release, CICR). In addition, cAMP can directly activate the guanine nucleotide exchange factor, EPAC, a Ras-like GTPase that may regulate the activity of RhoA, KATP channels, and, indirectly, the calcium-activated K+ (KCa) channels via the ryanodine receptors (RyRs) and Ca2+ levels. Once activated, PKA (1) increases K+ efflux through the large conductance calcium-activated K+ channels (BKCa), voltage-gated K+ (KV) channels, and KATP channels; (2) decreases the amount of Ca2+ in the cytoplasm by the inhibition of the inositol trisphosphate receptors (IP3Rs) on the sarcoplasmic reticulum (SR); (3) activates sarco/endoplasmic reticulum ATPase (SERCA) through phosphorylation and subsequent cleavage of the regulatory protein phospholamban (PLB); (4) decreases the affinity of the myosin light chain kinase (MLCK) to the Ca2+-CaM complex, thereby decreasing its ability to phosphorylate the myosin light chain (MLC); (5) accelerates the hydrolysis of active RhoA-GTP to inactive RhoA-GDP; and (6) inhibits the Rho-associated protein kinase (ROCK). Thus, PKA decreases plasma membrane potential (becomes more negative), decreases [Ca2+]c, dephosphorylates MLC (through the activation of the myosin light chain phosphatase, MLCP), and promotes vasodilatation.

Other abbreviations: ADP, adenosine diphosphate; AKAPs, A-kinase anchoring proteins; ATP, adenosine triphosphate; cAMP, cyclic adenosine monophosphate; GDI, guanine nucleotide dissociation inhibitor; GTP, guanosine triphosphate; MLCP, myosin light chain phosphorylated; Na+/K+-ATPase, sodium/potassium ATPase; NCX, sodium/calcium exchanger; NHE, sodium/proton exchanger; PMCA, plasma membrane calcium ATPase

Fig. 2.

Fig. 2

The dual role of protein kinase A (PKA) in the vascular smooth muscle (VSM) cells. In limiting its own vasodilatory actions, PKA exhibits the following effects: (1) increases the cytosolic calcium concentration [Ca2+]c by the activation of the membrane voltage-gated calcium (Cav) channels; (2) activates the ryanodine receptors (RyRs) on the sarcoplasmic reticulum (SR); and (3) weakly stimulates the myosin light chain (MLC). It is noteworthy that arachidonic acid (AA) may also be involved in the final effect by activating the Rho-associated protein kinase (ROCK) and inhibiting the myosin light chain phosphatase (MCLP). 

Other abbreviations: AKAPs, A-kinase anchoring proteins; ATP, adenosine triphosphate; BKCa, large conductance calcium-activated K+ channels; Ca2+-CaM, complex calcium-calmodulin; cAMP, cyclic adenosine monophosphate; Cav1.2, L-type calcium channels; GDI, guanine nucleotide dissociation inhibitor; GDP, guanosine diphosphate; GsPCR, G protein-coupled receptor of Gs type; GTP, guanosine triphosphate; IP3R, inositol trisphosphate receptor; KATP, ATP-dependent K+ channels; Kv, voltage-gated K+ channels; MLCK, myosin light chain kinase; MLCP, myosin light chain phosphorylated; Na+/K+-ATPase, sodium/potassium ATPase; NHE, sodium/proton exchanger; NCX, sodium/calcium exchanger; PMCA, plasma membrane calcium ATPase; SERCA, sarco/endoplasmic reticulum ATPase

Protein kinase G

Protein kinase G (PKG, syn. cGMP-dependent protein kinase) is a serine/threonine kinase. There are two types, PKG-1 located in the cytoplasm, and PKG-2, which is anchored to the plasma membrane due to myristylation at the N-terminus. In vascular relaxation, the PKG-1 is of higher importance [94], whereas the PKG-2 is important in some tissues, such as the intestine, brain, and kidney [231]. The PKG-1 has two isoforms, PKG-1α and PKG-1β.

Activation of PKG

PKG is activated mainly by cGMP. The PKG-1α is more sensitive, being activated by about tenfold lower concentration of cGMP than the PKG-1β. The cGMP is produced by guanylate cyclase (GC). There two types of GC. The plasma membrane-bound (pGC) is activated by natriuretic peptides [120], while the intracellular form is known as the soluble GC (sGC). It is typically activated by NO from the endothelial cells. Therefore, the sGC is sometimes referred to as an NO sensor [160]. The amount of cGMP is regulated by PDE, principally by the PDE3 and PDE5 isoforms. The PKG is also activated by cAMP, which acts as a partial agonist. The concentration of cAMP required for PKG activation is about 100 times higher than that of cGMP. Physiological importance is not clear; it might be related to the observation that if cytoplasmic concentration of cAMP increases, the amount of cGMP required for PKG activation becomes higher as well [231, 236].

Effects of activated PKG

Once activated, PKG phosphorylates several targets and, similar to PKA effects, the decrease in the plasma membrane potential (becomes more negative), decrease in [Ca2+]c, dephosphorylation of MLC, and vasodilatation occur. PKG (1) increases efflux of K+ ions through the BKCa, the Kv, and the KATP channels; (2) inhibits Cav1.2 (L-type calcium channels) and TRPC6 channels [217]; (3) activates SERCA on the SR by the phosphorylation of phospholamban [36]; (4) indirectly inhibits the IP3R channels by the inositol trisphosphate receptor-associated cGMP-kinase substrate (IRAG) [72, 207]; (5) inhibits the activation of RhoA by its phosphorylation and thereby inhibits the RhoA/ROCK signaling pathway [82]; and (6) phosphorylates GAP and, consequently, stimulates GTPase activity of the G-protein with subsequent reduction of active RhoA-GTP amount [221]. In the rabbit femoral artery, PKG inactivates MLCK and PKC, which decreases the levels of phosphorylated CPI-17 and prevents MLCP inhibition [114]. In the smooth muscles of the gastrointestinal tract, PKG inhibits PLCβ3 and thus reduces DAG and IP3 production [165], and in the gastric smooth muscle cells, the kinase augments MLCP activity through the phosphorylation of the protein M-RIP [143]. A similar mechanism may be functional in the VSM cells.

The PKG feedback

To date, little is known about the vasoconstrictive effects of PKG and its negative feedback. Basal NO production (see Section 4.1.) and active NO/sGC/PKG pathway are probably required for RhoA expression and, consequently, to trigger the RhoA/ROCK cascade [200].

The role of PKG is summarized in Fig. 3.

Fig. 3.

Fig. 3

The role of protein kinase G (PKG) in the vascular smooth muscle (VSM) cell relaxation. The activation of PKG is mediated by cyclic guanosine monophosphate (cGMP). cGMP is produced by the action of two types of guanylate cyclase (GC): the plasma-membrane bound form (pGC) and the soluble form (sGC). While pGC is activated by natriuretic peptides (e.g., C-natriuretic peptide—CNP), sGC is activated by nitric oxide (NO) generated by the endothelial cells. Upon activation of pGC or sGC, the production of cyclic guanosine monophosphate (cGMP) from guanosine triphosphate (GTP) takes place, with subsequent activation of PKG. The levels of cGMP are regulated by phosphodiesterases (PDEs), with isoforms PDE3 and PDE5 being predominant in the vasculature. Cyclic adenosine monophosphate (cAMP) can also act as a partial agonist and activate PKG. After activation, PKG (1) further activates the large conductance calcium-activated K+ channels (BKCa), the voltage-gated K+ (KV) channels followed by the opening of ATP-dependent K+ (KATP) channels allowing the efflux of K+ ions; (2) inhibits the Cav1.2 (L-type) calcium channels and the transient receptor potential cation (TRPC6) channels; (3) inactivates myosin light chain kinase (MLCK); (4) phosphorylates the GTPase-activating protein (GAP) with subsequent reduction of active RhoA-GTP; (5) inhibits protein kinase C (PKC) which, in turn, ceases to phosphorylate the phosphopeptide C-kinase potentiated protein phosphatase-1 inhibitor (CPI-17); as a result, the inhibition of the myosin light chain phosphatase (MLCP) is terminated; (6) activates sarco/endoplasmic reticulum calcium ATPase (SERCA) through the phosphorylation of phospholamban (PLB); (7) inhibits inositol trisphosphate receptors (IP3Rs) by the inositol trisphosphate receptor-associated cGMP-kinase substrate (IRAG). Thus, PKG activation contributes to VSM cell relaxation.

Other abbreviations: ADP, adenosine diphosphate; ATP, adenosine triphosphate; Ca2+-CaM, complex calcium-calmodulin; GDP, guanosine diphosphate; GTP, guanosine triphosphate; GAP, GTPase-activating protein; MLCP, myosin light chain phosphorylated; Na+/K+-ATPase, sodium/potassium ATPase; NCX, sodium/calcium exchanger; NHE, sodium/proton exchanger; PMCA, plasma membrane calcium ATPase; ROCK, Rho-associated protein kinase; RyR, ryanodine receptor; SR, sarcoplasmic reticulum

Ca2+ sparks and waves in the VSM cells

When [Ca2+]c in the VSM cells exceeds certain value, the contraction is triggered. Accordingly, the Ca2+ ions are usually associated with muscle contraction. However, the changes in the cytosolic Ca2+ concentration can be local in microdomains, with negligible alteration in global [Ca2+]c. The extracellular Ca2+ enters principally through the Cav1.2 channels with ~ 75% of the Ca2+ influx; the Cav3.2 and the TRP channels play minor roles. This Ca2+ entry is the principal source of the initial loading of SR. The Ca2+ sparks originate from the SR through the IP3R and RyR channels. The sparks produce a local (in the proximity of the plasma membrane) increase in the Ca2+ concentration reaching 10–100 µM [56]. This increase activates the adjacent calcium-operated structures, especially the BKCa channels. Their activation leads to K+ efflux which makes the membrane potential more negative and deactivates the neighboring voltage-gated channels [166]. The closure of the Cav channels closes the cycle of mutual modulation. Co-localization of all participants is necessary. The IP3R, RyR, Cav, and the BKCa channels form functional units [105, 259] that may be located in the membranal caveolae. The Ca2+ ions are pumped back from the cytoplasm to the SR by SERCA. The local Ca2+ levels thus oscillate. The roles of individual channels probably vary according to the type of the artery and species. In large arteries, both the RyR channels and the IP3R channels participate, while in the microcirculation, the latter may dominate [240]. Among the RyR channels, the RyR2 type may be principal [109]. One Ca2+ spark can trigger another; this is referred to as the spark-induced spark activation [191]. The activation can propagate along the VSM cell, and results in a Ca2+ wave. This propagation is supported by the CICR, in which the Ca2+ ions released from the SR activate further Ca2+ release [64]. This process is self-regulating, since from certain Ca2+ concentration, the IP3R and the RyR channels become closed.

The Ca2+ sparks secure important protection of small resistance arteries against excessive pressure. They can be enhanced by various stimuli, including mechanical ones [151], and mere shear stress resulting from physiological blood flow is sufficient. Surprisingly, the AT1a receptors for angiotensin II may be the participating mechanosensors [206]. Accordingly, angiotensin II was reported to stimulate the Ca2+ sparks [7]. Importantly, the above mechanism is functional only if the stimulus is appropriately small and the Ca2+ increase local. In contrast, the intraluminal pressure above 60 mmHg (observed ex vivo in mice mesenteric artery) leads to vessel contraction, which, in turn, is the consequence of the global rise in the Ca2+ cytoplasmic concentration [206]. Finally, in some vessels, the Ca2+ sparks result in the activation of the ClCa channels, which cause depolarization with subsequent opening of the Cav channels. This mechanism may play an enhanced role under hypertension [9, 28, 262].

Endothelium in vasodilatation

The inner lumen of the blood vessels is covered by a single layer of endothelial cells, exposed to a continuous blood flow on one side, and located close to the VSM cells on the other (except for the blood capillaries, which lack the smooth muscle). The endothelial cells are not just a barrier separating the smooth muscle from the blood, and allowing the penetration of chemicals from the blood, since the endothelium can also sensitively detect vasoactive stimuli, and can be, in turn, vasoactive itself. On the luminal surface of many vascular beds, glycocalyx is present. These extracellular polysaccharides form semipermeable barrier, act as shear stress sensors, and influence the NO generation, protect against cell adhesion and infiltration, and against inflammation (for a review, see [63]). The effects of endothelium on the VSM are mediated by chemical mediators and by changes in the membrane potential. While the former are released from the endothelial cells and act on the adjacent cells, the latter act principally via gap junctions (formed by connexins) between cells. This transmission occurs both myoendothelially and between nearby endothelial cells in the axial direction [103]. Potassium cations K+ released from the endothelium belong to chemical stimulants, but, in principle, they modify the membrane potential. Similarly, the gap junctions do not mediate just the bidirectional transfer of membrane potential, but possibly also of some mediators (Ca2+, IP3, small molecules < ~ 1 kDa) [100, 155]. The smaller the vessel, the more important the role of the gap junctions probably is. The vasodilatory substances including the K+ ions, produced by the endothelium, are referred to as endothelium-derived relaxing factors (EDRFs). Vasodilatation is also promoted by the endothelium-dependent hyperpolarization (EDH) [69, 113, 235, 243]. In contrast to the VSM, an overall increase in [Ca2+]c in the endothelial cells results in vasodilatation precisely due to the production of EDRFs and the induction of hyperpolarization. The opposite effect is promoted by the endothelium-derived contracting factors (EDCFs) and by membrane depolarization. As mentioned above, proper functioning of the blood vessels is conditioned with adequate vasoconstriction and vasodilatation at each moment. If the vascular response is inadequate and endothelium-mediated, endothelial dysfunction is a result. The endothelial dysfunction can be connected to a variety of disorders (for review, see [79, 187]). Impaired production of EDRFs is its main feature. Principal risk factors of endothelial dysfunction are age, obesity, increased oxidative stress, and diseases, such as hypertension and diabetes. In contrast, estrogens prevent endothelium-mediated vasoconstriction [8, 211] and thus promote vasodilatation. Surprisingly, phytoestrogens may relax the cerebral vessels in an endothelium-independent way by the inhibition of Ca2+ entry directly on the VSM cells, rather than through the vasorelaxant endothelial mechanisms [226].

Since this review addresses vasodilatation, the principal EDRFs and EDH will be discussed in detail. In contrast to the VSM cells, the formation of EDRFs is started off not only by the activation of the endothelial GPCR of Gs type, but, rather surprisingly, also of the Gq and Gi types. Agonists can originate from the blood, from the surrounding tissues, including autonomic neurotransmitters, or can even be autocrinal from the endothelium. Some physical stimuli display similar effects. The activation of the GPCR activates cellular pathways, and the activated kinases subsequently phosphorylate their target proteins. As a result, the production of EDRFs and the modification of the membrane channel activity follow. Some vasoactive stimuli may activate the endothelial membrane channels directly. Once released from the endothelium, EDRFs both influence the neighboring cells and act in an autocrine manner. Some of their effects are manifested on the cell membrane, others are intracellular. K+ ions play an important role. Their efflux decreases the membrane potential (becomes more negative) which is propagated by myoendothelial (MEGJ) and endothelial (EEGJ) gap junctions. The neighboring cells are simultaneously influenced by the increase of K+ concentration in the adjacent extracellular space. NO has long been considered as the most important EDRF and has thus been the subject of intense research. However, recently published data show that NO may be the dominant EDRF only in large arteries, while in smaller resistance arteries, most likely EDH, is probably principal. The next sections summarize the data on the most important EDRFs: NO, H2O2, H2S, CO, derivatives of arachidonic acid, and some others.

NO

In the blood vessels, nitric oxide is formed from L-arginine by the constitutive endothelial NO synthase (eNOS) together with L-citrulline. The eNOS additionally produces the superoxide anion O2•− [229].

eNOS

Inactive eNOS is located in the plasma membrane invaginations, caveolae, anchored by myristoylation, which secures colocalization with other structures. It is also in the Golgi complex, but its capacity to generate NO is blunted there. The caveolae formation is associated with specific proteins (the small integral membrane proteins caveolins, filamentous peripheral membrane proteins cavins, Eps15 homology domain) and with membrane lipids including cholesterol [111]. The inactive eNOS is bound to caveolin-1 and becomes activated following caveolin-1 displacement by the Ca2+-CaM complex. Various cofactors are required for the NO production, such as tetrahydrobiopterin (BH4), flavin adenin dinucleotide, flavin mononucleotide, and heme [5, 229]. Optimal BH4 concentration is of special importance, since BH4 mediates the dimerization of eNOS, necessary for NO production. Under the eNOS uncoupling, the resultant monomers preferentially produce superoxide anion O2•−, which can be converted to another important EDRF, H2O2 (see Sect. H2O2) [46, 186]. The non-caveolar caveolin-1 domains or scaffolds also exist indicating a possible non-caveolar association with eNOS. However, these domains are structurally and functionally distinct from caveolae as reported for the caveolin-1 signaling [106, 131, 213, 261].

The activity of eNOS is effectively regulated by posttranslational modifications [34, 43, 228], and by the heat shock protein 90 (HSP90). Generally, they modify the sensitivity of eNOS to the Ca2+-CaM complex. The eNOS can be posttranslationally phosphorylated on tyrosine, serin, and threonine. The NO production is augmented when Ser-1177, Tyr-81, Ser-615, and Ser-633 are phosphorylated, and Thr-495, Tyr-657, and Ser-114 dephosphorylated. The phosphorylation of Ser-1177 and Thr-495 can even switch between these two positions [154, 235], and Thr-495 phosphorylation may regulate the ratio of NO and superoxide produced [91]. Many kinases participate in the phosphorylation of eNOS, among them the calcium-calmodulin-dependent protein kinase II (CaMKII) [61], PKA, protein kinase B (PKB, Akt), PKC, AMP-activated protein kinase (AMPK), and ROCK [43, 91, 154]. However, the possible link between eNOS phosphorylation/dephosphorylation and its activity has not been fully clarified, as reported recently for Ser-1177 [54].

The eNOS can also be posttranslationally S-nitrosylated, acetylated, acylated, glycosylated, and glutathionylated [91]. The S-nitrosylation of Cys-94 and Cys-99 decreases the enzyme activity and can be regarded as an autoregulation of NO production. Acetylation both decreases (Lys-494 and Lys-504) and increases (Lys-609) the activity of eNOS. Interestingly, the Lys-609 acetylation can be induced by acetylsalicylic acid and this effect is independent of its cyclooxygenase inhibition [107]. The acylation of eNOS also mediates its localization in the caveolae [91] (notably, from a chemical point of view, acetylation is a form of acylation). Glutathionylation of Cys-689 and Cys-908 leads to uncoupling of the dimer and superoxide production, and can be reversed by the AT1 blocker, telmisartan [116]. The HSP90 facilitates caveolin-1 displacement by the Ca2+-CaM complex [77] and enhances the interaction of eNOS with PKB [62]. This process modulates the folding of eNOS, regulates hem insertion into the immature enzyme [16], and protects against calpain-mediated degradation [11]. NO production is further influenced by other factors, such as the eNOS traffic inducer (NOSTRIN) and the eNOS interacting protein (NOSIP), which support the translocation of eNOS from the caveolae to the intracellular region. Interestingly, NOSTRIN was reported to interact directly with the membranous cholinergic M3 receptors [119].

Production of NO

The production of NO can be stimulated in two ways, typically by an increase in [Ca2+]c and direct activation of eNOS by the Ca2+-CaM complex. This cascade can be triggered by the agonists on the GPCR of the Gq type, which initiate the transfer of both sarcoplasmatic and extracellular Ca2+ into the cytoplasm. Alternatively, the [Ca2+]c remains at the resting level, and NO production increases with the rise in eNOS sensitivity to the Ca2+-CaM as a result of posttranslational modifications with the participation of HSP90. The fluid shear stress can serve as an example. When detected by the endothelial mechanosensors, the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) is activated. Consequently, kinases PKB [60] and PKA [19] are activated and these enzymes further phosphorylate eNOS on Ser-1177.

The production of NO is regulated by kinases and phosphatases in both positive and negative ways. The [Ca2+]c increase activates the dependent kinases, including CaMKII and PI3K, which, in turn, activate other kinases, such as PKB. Accordingly, the vasodilatory effect of bradykinin (the GPCR agonist of the Gq type) is mediated by CaMKII [61]. In contrast, the active PKC phosphorylates eNOS (Thr-495) and inhibits its activity [154]. This process can be regarded as a negative feedback after endothelial Gq receptor activation. The phosphatases may act in an analogous fashion. NO production is modified by various circumstances, such as hypoxia that increases the association of eNOS-HSP90 and PKB [183]. Other EDRFs support (H2S) [122] or diminish (CO) the NO production [126]. NO formation decreases after the activation of the endothelial RhoA/ROCK pathway [253]. Last but not the least, NO is not only synthesized de novo. Various products of NO metabolism, such as S-nitrosothiols, nitrites, and nitrates, can serve as reservoirs, capable of re-releasing NO under certain conditions. For example, hemoglobin acts as an oxygen sensor and generates NO from nitrites during hypoxia [96]. Mitochondrial cytochrome c oxidase acts analogously [27]. Via this mechanism, the organism can improve blood flow to hypoxic tissues. On the other hand, hemoglobin also works as an NO scavenger and thus regulates its diffusion into the VSM.

Effects of NO

The lifetime of the vascular NO is generally short, depending on the tissue and state and in the vascular lumen it is ~ 2 ms [90, 224]. NO molecules quickly diffuse from the endothelium radially to the VSM cells and activate the NO/sGC/PKG pathway there. The sGC contains a heme moiety that easily binds NO and probably detects even its picomolar levels. The vasodilatory effects of the activated PKG in VSM have already been described (see Sect. Protein kinase G). NO also acts independently of the PKG; the pathway involves the activation of SERCA on the SR by NO-dependent S-glutathionylation via peroxynitrite (and thus depends not only on NO and GSH, but also on the superoxide presence) [2]. In the skeletal muscle, NO directly activates the RyR1 channels on the SR by S-nitrosylation [214]; however, the same effect in the VSM cells remains uncertain, since NO was reported to suppress the Ca2+ sparks (see Sect. Ca2+ sparks and waves in the VSM cells) in the small mesenteric arteries [184]. The vasodilatory effects of NO are supported by a decrease in the plasma membrane potential (becomes more negative) in the endothelial cell which further increases the production of endothelial NO [149] and is transmitted to VSM via MEGJ [196]. In addition, NO may directly open the BKCa channels and contribute to vasodilatation in some vessels [156]. Simultaneously, NO inhibits endothelin-1 synthesis directly in the endothelium and its downstream cascade [21]. In addition to direct vasoactivity, NO exhibits effects on blood. Its molecule reduces platelet aggregation and the expression of the adhesion molecules on the endothelial surface. Reciprocally, the aggregating platelets release 5-HT and ADP, which increase NO production [234, 235]. Notably, the vasodilatory effects of NO are regarded as beneficial, but excessive NO supplementation was, somewhat surprisingly, found contra-productive in clinical trials [171, 225, 257]. The nitroglycerin-induced endothelial dysfunction, oxidative stress, and nitrate tolerance could result from an imbalance among exogenous NO and endogenous vasoactive factors [205].

The role of NO in vasodilatation is summarized in Fig. 4.

Fig. 4.

Fig. 4

The role of endothelial nitric oxide synthase (eNOS), nitric oxide (NO), and hydrogen peroxide (H2O2) in the endothelial cells (EC) and the vascular smooth muscle (VSM) cells. Inactive eNOS is located in the plasma membrane invaginations, caveolae, bound to the protein caveolin-1 (Cav1). The binding of an agonist to the G protein-coupled receptor of the Gq type (GqPCR) on the plasma membrane results in the activation of phospholipase C (PLC) with the ensuing production of diacylglycerol (DAG) and inositol trisphosphate (IP3). IP3 binds to inositol trisphosphate receptors (IP3Rs) on the sarcoplasmic reticulum (SR) and induces the release of calcium from the SR and hence subsequent formation of the calcium-calmodulin (Ca2+-CaM) complex. eNOS becomes activated after caveolin-1 displacement by the Ca2+-CaM complex. Various cofactors are required for the production of NO, such as tetrahydrobiopterin (BH4), flavin adenine dinucleotide (FAD), flavin mononucleotide, and heme. In particular, the BH4 concentration is of special importance since BH4 enables the dimerization of eNOS and the production of NO. NO and L-citrulline are formed from L-arginine by the action of eNOS in its dimerized form. On the contrary, upon eNOS uncoupling, the eNOS monomers preferentially produce the superoxide anion O2•−,which can be converted to H2O2 as another endothelium-derived relaxing factor (EDRF). The activity of eNOS is regulated by several factors, among others the heat shock protein 90 (HSP90) which alters the sensitivity of eNOS to the Ca2+-CaM complex. In addition, post-translational modifications of eNOS on tyrosine (Tyr), serine (Ser), and threonine (Thr) sites interfere with NO production. Several kinases participate in the phosphorylation of eNOS, such as the CaMKII and phosphatidylinositol-3-kinase (PI3K), protein kinase B (PKB), and protein kinase A (PKA) (also protein kinase C (PKC) and Rho-associated protein kinase (ROCK), not shown in the figure). The shear stress caused by the blood flow is detected by endothelial mechanosensors, giving rise to the activation of PI3K, with subsequent activation of PKB and PKA. Then, PKB and PKA phosphorylate eNOS. Other factors, such as hypoxia, increase the association of eNOS-HSP90 and PKB. HSP90 facilitates the displacement of caveolin-1 by calmodulin and potentiates the interaction of eNOS with PKB. In addition, NO production is influenced by factors, such as the eNOS traffic inducer (NOSTRIN) and eNOS interacting protein (NOSIP) which facilitate the translocation of eNOS from caveolae to the intracellular region. There are EDRFs that enhance NO production, such as hydrogen sulfide (H2S), whereas carbon monoxide (CO) acts as a suppressor. Besides, the inhibition of the endothelial system RhoA/ROCK increases NO production. Interestingly, NO is formed not only de novo, but also as a product of the metabolism of nitrogen compounds, such as S-nitrosothiols, nitrites, and nitrates that can serve as reservoirs, capable of releasing NO under specific conditions. After being formed in the endothelial cells, NO rapidly diffuses to the adjacent VSM cells, where the molecule activates the soluble guanylate cyclase (sCG), with subsequent production of cGMP and protein kinase G (PKG) activation. In the VSM cells, NO can react with O2•− to furnish peroxinitrite (OONO), which then activates the sarco/endoplasmic calcium ATPase (SERCA) on the sarcoplasmic reticulum (SR) by glutathionylation. H2O2 is produced from O2by glutathionylation. H O is produced from− under superoxide dismutase (SOD) catalysis. The effects of H2O2 on EC probably include the activation of the K+ channels, and the effects on the VSM are probably dependent on its concentration. While low levels give rise to PKG activation and subsequent vasodilatation, high H2O2 concentrations act as endothelium-derived constricting factor (EDCF) (not shown in the figure).

Other abbreviations: cGMP, cyclic guanosine monophosphate; EEGJ, gap junctions between adjacent endothelial cells; GSH, glutathione; GTP, guanosine triphosphate; MEGJ, myoendothelial gap junctions; PIP2, phosphatidylinositol bisphosphate; PKA, protein kinase A; PKB, protein kinase B; RyR, ryanodine receptor; SERCA-SSG, sarco/endoplasmic reticulum calcium ATPase S-glutathionylated; TRPC, transient receptor potential cation channels

H2O2

Production of H2O2

Endothelial H2O2 synthesis (mainly) from the superoxide anion O2•−is catalyzed by superoxide dismutase (SOD). The superoxide radical-anion is produced by many enzymatic systems, including NADPH oxidase, xanthine oxidase, NOS, mitochondrial respiratory chain, and also as a by-product of epoxyeicosatrienoic acid synthesis (see Sect. Epoxyeicosatrienoic acids). In the vascular system, the NADPH oxidases are the main O2•−generators [39]. NOX complexes produce ROS using NAPDH and O2 as substrates. Various NOX isoforms were found in humans (5 isoforms) and rodents (4 isoforms) [13, 39, 124, 159]. Superoxide produced by eNOS is one of the important precursors of H2O2 in the endothelium (see Fig. 4). However, there are differences among species, specific arterial beds, and influence of factors, such as development, age, and general health state [133, 146148, 204, 205]. The eNOS contains oxygenase and reductase domains, where superoxide is produced. In the latter case, the production is independent of the Ca2+-CaM complex, and unmodifiable by eNOS inhibitors, such as L-NAME. Superoxide is physiologically produced together with NO, and subsequently gives rise to the formation of H2O2, which acts as one of the EDH factors (see Sect. Endothelium-dependent hyperpolarization). Upon eNOS uncoupling to monomers, superoxide production prevails, and shifts the NO/superoxide ratio. The relative excess of the superoxide is not only reflected in an increased amount of H2O2, but also in the conversion to other metabolites. Among them, the highly reactive peroxynitrite ONOO arises from the reaction with the remaining NO, whose availability is diminished this way. The important cofactor BH4 is among the molecules oxidized by the peroxynitrite; its deficiency results in further monomerization of eNOS and the decrease of NO production.

Effects of H2O2

Cytosolic concentration of H2O2 is the key factor that determines its vascular effects. As an EDH factor, its level is quite low, ranging approximately from units to low tens of µM concentrations [205, 249]. In the VSM, H2O2 molecules act principally through the PKG activation, which leads to vasodilatation (see Sect. Protein kinase G) [47, 258]. At higher concentrations, hydrogen peroxide acts as EDCF and mediates vasoconstriction, probably via elevated levels of contractile factors, such as thromboxane TxA2, excessive superoxide production, and elevated [Ca2+]c in VSM [67]. The H2O2-derived ROS have been found to upregulate connexins Cx40 and Cx45 in human cardiomyocytes [121] (the Cx40 may participate in endothelium dependent vasodilatation conducted along the vessel [208]). The involvement of H2O2 and gap junctions in endothelium-derived hyperpolarizing response to bradykinin was observed in omental arteries and veins, isolated from pregnant women [84].

Even though H2O2 molecules are formed in vessels of all diameters, its role significantly increases in microcirculation. The dominance of H2O2 over NO may be at least partially mediated by the less intense NO production in small vessels due to augmented eNOS inactivation by caveolin-1 [194]. Importantly, NO and H2O2 do not compete, but rather complement each other as vasodilators. The key role H2O2 in microcirculation is supported by the finding that a long-term antioxidant therapy does not improve patient mortality [17]. However, the role of NO and H2O2 cannot be generalized. The controlling mechanisms are highly heterogenous among arteries and even within one artery (a proximo-distal manner) and influenced by a plethora of factors (development, aging, general health, and disease). The endothelium is considered as the principal source of H2O2, but it is also synthesized directly in the VSM cells. Interestingly, H2O2 is among the vasodilatory substances produced by the brown adipose tissue, and this source was reported to induce the PKG-1α activation [65, 93]. Surprisingly, the extracellular production of superoxide can result in redox modifications of intracellular domains including eNOS. This effect could be mediated by the conversion of O2.− to H2O2 which has higher stability as well as the ability to cross biological membranes [22].

Vascular gasotransmitters

Gasotransmitters are small gaseous molecules, generated in cells under both physiological and pathological conditions. They are dissolved in biological fluids and freely pass through the plasma membrane and intracellular organelle membranes. They interact with plenty of targets and influence various biological pathways. The best known vascular gasotransmitters are H2S, CO, and, in principle, also NO, but, for historical reasons, it is usually dealt with separately.

H2S

H2S is generated from L-cysteine. In the vascular system, its production is catalyzed mainly by cytosolic cystathionine γ-lyase. Other ways of production mediated by cystathionine-β-synthase and cysteine aminotransferase/3-mercaptopyruvate sulfurtransferase are minor. It is also formed in PVAT. The production of H2S is stimulated by the Ca2+-CaM complex, hypoxia, NO, ROS, and shear stress, and decreases with age, obesity, hypertension, and diabetes. Hydrogen sulfide participates in signal transduction, mainly through persulfidation of cysteine residues (-SSH) in important biomolecules. Among other functions, the molecule exhibits vasodilatory action. Effects of H2S in the VSM cells are complex. Hydrogen sulfide (1) activates the potassium channels (the BKCa, Kv7.4, and KATP) leading to a decrease in membrane potential; (2) inhibits the IP3R receptors and decreases [Ca2+]c; (3) decreases the intracellular pH via Cl/HCO3 exchanger; (4) increases the cGMP levels, probably through the PDE inhibition; and (5) reacts with NO to furnish nitrosothiol and thus decreases NO availability. In the endothelium, H2S activates the small (SKCa) and intermediate (IKCa) calcium-activated K+ channels which leads to a decrease in membrane potential. Importance of H2S increases with decreasing diameter of the vessel [108, 246, 250]. H2S donors may be therapeutically promising, and many structural types are studied for this purpose (sulfide salts, allicin derivatives, cysteine derivatives) [260].

CO

Carbon monoxide physiologically arises during heme degradation, catalyzed by hemoxidase. Its production is enhanced by various stimuli, such as hypoxia and hypotension, and the increase is based on hemoxidase posttranslational modifications with the participation of the Ca2+-CaM complex. In the vessels, CO exhibits vasodilatory effects, including (1) support of the frequency and amplitude of Ca2+ sparks; and (2) the sparks coupling with the BKCa channels. Accordingly, the hemoxidase is colocalized with the BKCa channels. CO (3) activates the sGC; however, it is a weaker activator than NO. Similar to the H2S donors, CO-releasing molecules (CORMs) are searched for, with organometallic compounds, oxalates, aldehydes, and boranocarboxylates being tested among others [126, 132, 175].

Interplay of gasotransmitters

The gasotransmitters mutually influence the formation and, likely, also the action of each other. NO stimulates both cystathionine γ-lyase and hemoxidase. In contrast, CO inhibits both the cystathionine γ-lyase and eNOS, while H2S inhibits the hemoxidase, but stimulates NO production. The latter process is executed via the S-sulfhydration of eNOS that prevents the enzyme monomerization, through the eNOS phosphorylation by PKB, and through Ca2+ released from the SR. NO and H2S might also interact together and form a yet uncovered vasorelaxation mediator [246].

The role of gasotransmitters in vasodilatation is summarized in Fig. 5.

Fig. 5.

Fig. 5

The role of the gasotransmitters hydrogen sulfide (H2S) and carbon monoxide (CO) in the endothelial cells (EC) and the vascular smooth muscle (VSM) cells. H2S is formed from L-cysteine. The formation is catalyzed mainly by the cytosolic cystathionine γ-lyase (CSE), while minor pathways involve cystathionine-β-synthase (CBS) and cysteine aminotransferase/3-mercaptopyruvate sulfurtransferase (3-MST).Various stimuli increase H2S production, such as the calcium-calmodulin complex (Ca2+-CaM), hypoxia, nitric oxide (NO), reactive oxygen species (ROS), and shear stress. After being produced, H2S participates in signal transduction, mainly through persulfidation of the cysteine residues (-SSH) in physiologically important biomolecules. In EC, H2S activates the small-conductance and intermediate-conductance calcium-activated K+ channels (SKCa and IKCa, respectively), which decreases membrane potential. In addition, H2S diffuses into the adjacent VSM cells where the substance (1) activates the potassium channels (large conductance calcium-activated K+ (BKCa), voltage-gated K+ (KV7.4), and ATP-dependent K+ (KATP) channels) thus contributing to the membrane potential decrease (becomes more negative); (2) inhibits the inositol trisphosphate receptors (IP3R) on the sarcoplasmic reticulum (SR) leading to a decrease in the cytosolic calcium concentration [Ca2+]c; (3) decreases intracellular pH via the Cl/HCO3 exchanger; (4) increases the cGMP levels, probably through phosphodiesterase (PDE) inhibition; and (5) reacts with NO to give nitrosothiol, which decreases NO bioavailability. The overall net effect of all these pathways is VSM relaxation. In EC, CO inhibits endothelial nitric oxide synthase (eNOS).

Other abbreviations: Ca2+-CaM, complex calcium-calmodulin; Cav1, caveolin-1; cGMP, cyclic guanosine monophosphate; DAG, diacylglycerol; EEGJ, gap junctions between adjacent endothelial cells; GqPCR, G protein-coupled receptor of Gq type; GTP, guanosine triphosphate; IP3, inositol trisphosphate; MEGJ, myoendothelial gap junctions; PI3K, phosphatidylinositol-3-kinase; PIP2, phosphatidylinositol bisphosphate; PKB, protein kinase B; PLC, phospholipase C; ROS, reactive oxygen species; RyR, ryanodine receptors; SERCA, sarco/endoplasmic reticulum calcium ATPase; SOD, superoxide dismutase; TRPC, transient receptor potential cation channel

Endothelial derivatives of arachidonic acid

Arachidonic acid is released from the plasma membrane by phospholipase A2 (PLA2). There are three subtypes of PLA2, secreted sPLA2, cytosolic cPLA2, and calcium-independent iPLA2. Among them, the cPLA2 is the most important for the arachidonic acid release in the vascular system. PLA2 is activated by an increase in endothelial [Ca2+]c, brought about by agonists on the endothelial GPCR of the Gq type [242] as well as in response to the blood-flow induced shear friction [59]. Notably, the same stimuli increase NO production, which inhibits further EDH-dependent vasodilatation (see Sect. Endothelium-dependent hyperpolarization) and provides a negative feedback [168]. The released arachidonic acid is metabolized by three principal pathways: by cyclooxygenase (COX-1 and 2), cytochrome P450 (CYP), and lipoxygenase (LOX) [157]. The COXs yield prostaglandin PGH2 which is further converted to PGI2 (prostacyclin), PGE2, PGF, and thromboxane TxA2. The CYP are heme-containing enzymes producing four epoxyeicosatrienoic acids (EETs) and hydroxyeicosatetraenoic acids (HETEs), such as 20-HETE. LOX metabolizes arachidonic acid into leukotrienes (LTs), and various HETEs are also synthesized. The formation of individual metabolites depends on the cell type and available enzymes. The resultant effect is further determined by the expression of the receptors in individual tissues. Importantly, the metabolites of the same enzymatic pathway can have opposite vascular effects. Thus, the COX product PGI2 produces vasodilatation, while thromboxane TxA2 is vasoconstrictive. The same is true for the EETs and 20-HETE. Depending on the conditions, the effects can be variable. Thus, the PGE2 is usually a vasodilatory compound; this prostanoid, however, displays contractile effects upon central administration to the cerebral ventricles [252]. The regulation of the blood flow by the products of arachidonic acid metabolism is based on the interplay among them, with the ratio between PGI2 and TxA2 having probably the key role. Among EDRFs, the PGI2 and EETs are of the highest importance.

Prostaglandin PGI2

In the vascular system, the PGI2 production has been associated with the endothelial COX-2; however, COX-1 may predominate under physiological conditions. Accordingly, the COX-1 and PGI2 synthase are co-localized [110]. The PGI2 synthase is by far the most abundant prostanoid synthase expressed in the endothelial cells (85.9% in normotensive rats and 93.7% in spontaneously hypertensive rats SHR, both 36 weeks old) [220]. Consequently, the PGI2 is the main COX product formed in the endothelium. In females, its production is stimulated by estrogens [211], in particular 17β-estradiol [6]. Following its release from the endothelium, the PGI2 stimulates the IP1 receptors on the VSM cells (GPCR of the Gs-type) and activates the AC/cAMP/PKA and AC/cAMP/EPAC cascades described above (see Sect. Protein kinase A). Analogous to NO, the PGI2 inhibits the platelet aggregation [210]. Importantly, the PGI2 vasodilatation decreases with aging. Accordingly, the expressions of COX-1, COX-2, and TxA2 synthases but not that of the PGI2 synthase increased in the rats of 36 and 72 weeks of age [98, 220].

Epoxyeicosatrienoic acids

The EETs are formed as a result of the catalytic activity of the CYP epoxigenases 2 C8/9. Their molecules induce the NO-independent vasodilatation in multiple ways. At micromolar concentrations, they activate the endothelial and smooth muscle KCa channels and cause a decrease in the plasma membrane potential [178]. The acids are also agonists of the GPR40 receptor, which is coupled with both Gq and Gs proteins. The EETs probably interact with some other sites as well [177]; the TRPV4 and TRPC1 channels are among the candidates. Since they form a complex with the BKCa channels on the VSM, these channels may become activated in this way [141, 239]. Two possible mechanisms of the EETs-mediated vasodilatation have been described: (1) on the endothelial cells, they may activate the GPCR of the Gq type with [Ca2+]c increase, which results in the IKCa and SKCa channel activation and re-/hyperpolarization. The membrane potential is transferred to the adjacent VSM cells through the activation of the Na+/K+ ATPase and Kir channels opening and via the MEGJ; or (2) the GPCR of the Gs type may be activated directly on the VSM cells with the opening of the BKCa, Kv, and subsequently of Kir channels. Activation of the BKCa channels may be mediated by CO, which is produced after the activation of heme oxygenase [104, 192]. Both mechanisms may operate simultaneously, depending on the type of the vessel and species [23, 71, 228, 254, 255]. Furthermore, the role of individual EETs may not be identical. 11,12-EET is generated during hypoxia and targets the endothelial TRPC6 [112], whereas the action of the 5,6-EET is associated with mechano- and osmotic stimulation and activation of the TRPV4 channels [15, 239]. The EETs are metabolized by the soluble epoxide hydrolase (sEH) to dihydroxyeicosatetraenoic acids (DHETEs), whose biological activities are not fully understood yet; however, it is likely that they modify the endothelial Ca2+ levels [83].

Products of LOXs

The endothelial cells contain various lipoxygenases. 5-LOX produces leukotrienes with concomitant collaboration of the 5-LOX-activating protein (FLAP). 12/15-LOX, 12-LOX, and 15-LOX produce a number of metabolites, among them 12(S)-hydroxyeicosatrienoic acid (12-HETE), 15-HETE, and 11,12,15-trihydroxyeicosatrienoic acid (11,12,15-THETA). The 15-LOX pathway represents the first known example of inducible endothelium-derived hyperpolarizing factor [24]. Notably, 12-LOX is also present in the blood platelets. In general, the LOX products are vasoactive and can both dilate and constrict arteries, depending on the vascular bed and species. This vasodilatation includes the activation of the BKCa channels [57].

The role of endothelial derivatives of arachidonic acid in vasodilatation is summarized in Fig. 6.

Fig. 6.

Fig. 6

The role of derivatives of arachidonic acid (AA) produced in the endothelial cells (EC) in the vascular smooth muscle (VSM) cell relaxation. The binding of an agonist to the G protein-coupled receptor of the Gq type (GqPCR) causes an increase in the cytosolic calcium concentration [Ca2+]c on the ECs which, in turn, activates phospholipase A2 (PLA2). By the action of PLA2, arachidonic acid (AA) is released from the membranes and afterwards metabolized by cyclooxygenases (COX-1 and COX-2), cytochrome P450 (CYP), and lipoxygenase (LOX). The COX yield prostaglandin H2 (PGH2) which can be further converted into prostaglandins PGI2 (prostacyclin), PGE2, and PGF. The CYP are membrane and heme-containing enzymes producing four epoxyeicosatrienoic acids (EETs) and hydroxyeicosatrienoic acids (HETEs). The 5-lipoxygenase (5-LOX) and 5-lipoxygenase activating protein (FLAP) metabolizes arachidonic acid into leukotrienes (LTs) and various hydroxyeicosatrienoic acids. The metabolites of one enzymatic pathway can have opposite effects on the vascular system. For instance, the COX product prostacyclin (PGI2) is vasodilatory, while thromboxane (TxA2), produced by the platelets, is vasoconstrictive. PGE2 is generally a vasodilatory prostanoid, but the substance also can, under certain conditions, act as vasoconstrictive. It is worthy to mention that the regulation of the blood flow by the metabolites of AA is based on the interplay among them, with the ratio between PGI2 and TxA2 being the most important. The PGI2 synthase is the most abundant prostanoid synthase expressed in ECs and, consequently, PGI2 is the main COX product formed in the endothelium. Endothelial production of PGI2 is stimulated by estrogens (e.g., 17β-estradiol). After being released from the endothelium, PGI2 stimulates its IP1 receptor on the VSM. This G protein-coupled receptor of the Gs type (GsPCR) activates adenylate cyclase (AC) with subsequent production of cAMP and protein kinase A (PKA) activation. EETs are formed by CYP epoxygenases 2 C8/9. EETs produce vasodilatation by activation of the G protein-coupled receptor of the Gq type/phospholipase C/inositol trisphosphate + diacylglycerol/protein kinase C (Gq type/PLC/IP3 + DAG/PKC) pathway on EC. This pathway involves the transient receptor potential cation channels (TRPC1, TRPC3, and TRPC6), which enable an influx of [Ca2+]c. Subsequent activation of the small-conductance and intermediate-conductance calcium-activated K+ channels (SKCa and IKCa, respectively) results in the decrease of membrane potential (becomes more negative), which is transferred to the VSM through the myoendothelial gap junctions (MEGJ) and via the activation of Na+/K+ ATPase and inward-rectifier K+ (Kir) channels. Another possible mechanism is the activation of the G protein-coupled receptor of the Gs type/adenylate cyclase/cyclic adenosine monophosphate/protein kinase A (GsPCR/AC/cAMP/PKA) pathway directly on the VSM with subsequent opening of the large conductance calcium-activated K+ channels (BKCa), voltage-gated K+ channels (Kv), and inward-rectifier (Kir) channels.

Other abbreviations: ATP, adenosine triphosphate; cAMP, cyclic adenosine monophosphate; CO, carbon monoxide; EEGJ, gap junctions between adjacent endothelial cells; GTP, guanosine triphosphate; IP3R, inositol trisphosphate receptors; MEGJ, myoendothelial gap junctions; RyR, ryanodine receptors; SERCA, sarco/endoplasmic reticulum calcium ATPase; SR, sarcoplasmic reticulum.

Other endogenous vasodilatory substances

The natriuretic peptide C (CNP) is formed and stored in the endothelium. The regulation of its expression is complex. It is enhanced by, e.g., shear stress [172], the transforming growth factor β, or the tumor necrosis factor α, and suppressed by the vascular endothelial growth factor (VEGF) [202]. The CNP vasodilatation is based on the activation of the membrane pGC with the initiation of the cGMP/PKG pathway [30].

Insulin produces vasodilatation which is mediated through the PKB activation of eNOS [1, 162] but not by opening of the KCa and KATP channels [1]. Accordingly, insulin resistance is associated with a decreased bioavailability of NO and endothelial dysfunction [238].

Ghrelin is another vasoactive substance capable of dilating the small arteries via the mediacy of NO and possibly also NO-independently. The substance exhibits indirect vascular effects through the stimulation of diuresis and possibly through the autonomic system [145, 179, 180].

Vasodilatory effects were reported for the active form of vitamin D, paricalcitol, in the chronic kidney disease patients [263]. Similarly, adiponectin, an important adipocytokine secreted by the adipocytes, brings about NO-dependent vasodilatation of the retinal arterioles, which is partially dependent on AMPK activity [174]. The VEGF is not only a key factor during angiogenesis, but it also modulates NO production [247]. The therapy with VEGF inhibitors is associated with the risk of hypertension and embolism [158, 181]. The endothelium-dependent vasodilatation may be supported by a number of natural substances, such as polyphenols including flavonoids [42, 97, 153, 164, 170, 182] and phytoestrogens. Notably, the same is true for the selective estrogen receptor modulators (SERMs) [128, 226, 244].

Endothelium-dependent hyperpolarization

The hyperpolarization of the VSM plasma membrane leads to vasodilatation. If this hyperpolarization originates from the endothelium, it is referred to as EDH. Hyperpolarization is transmitted to the VSM in two main ways: (1) by K+ ions effluxed by the endothelial Ca2+- activated potassium channels (IKCa and SKCa); and (2) by MEGJ.

Triggering of EDH

The EDH can be triggered by various mechanisms. (1) Ca2+ ions are spontaneously released from the endothelial SR through the IP3R channels, and activate the KCa channels in their proximity [125]. Similarly, (2) the spontaneous extracellular Ca2+ sparklets are secured by certain TRP channels [12, 50, 176] and their probability increases with the decrease in intraluminal blood pressure below ~ 60 mmHg [12, 206]. (3) Increased [Ca2+]c in the VSM cells during vasoconstriction leads to a rise in [Ca2+]c in the adjacent endothelial cells as well. This “negative feedback” is not fully understood and could be mediated by IP3 or by Ca2+ itself passing from the VSM cells into the adjacent endothelial cells through the MEGJ. The [Ca2+]c increase can also be triggered for example by agonist binding the endothelial GPCR of Gq type. Additionally, the vasoconstrictors can activate the TRPV4 channels in myoendothelial projections which results in Ca2+ sparklets and endothelial KCa channel activation (reported for mouse mesenteric arteries) [95]. Last but not the least, (4) increase in endothelial [Ca2+]c can be mediated by the activation of several endothelial shear stress responsive ion channels [142, 152]. Regarding the shear stress, new details have recently emerged. The endothelial cells are constantly exposed to the force of blood flow and rolling erythrocytes. In detection of the mechanical stimulation, the membranal channels play an important role. Among them, the Kir channels seem to be of special interest. The Kir channels are classically involved in maintaining resting membrane potential. In the vessels, the Kir2.x channel subtype is the most abundant. Endothelial Kir2.1 channels are shear-sensitive and may represent the major contributor of flow induced dilatation [3, 173, 199]. The cytoskeletal and scaffolding proteins also contribute to mechanosensing. These proteins interact and modify the signaling microdomains at the cell membrane. Caveolin-1, a protein which participates in the formation and stabilization of caveoleae, negatively regulates the Kir2 channel activity [85, 199]. Actin, the most abundant cytoskeletal protein, can switch from polymerized to depolymerized states according to external mechanical stimuli [29]. Dystrophin, a sub-membrane cytoskeletal protein, interacts with various proteins including syntrophins forming a dystrophin-associated protein complex (DAPC) which anchors the actin cytoskeleton to the extracellular matrix [37, 53, 199]. The syntrophins were shown to connect Kir2 channels directly to DAPC and cytoskeleton [127, 199]. Additionally, the functionality of Kir channels is influenced by local lipid microenvironment in the cell membrane, in particular by the content of phosphatidylinositol 4,5-bisphosphate (PIP2) and cholesterol [199]. While the PIP2 stabilizes the Kir channels in the active (open) state [86], cholesterol exhibits an opposite effect [129]. Thus, the endothelial dysfunction during hypercholesterolemia may be at least partially explained by Kir2.1 channel inhibition [4, 199].

The endothelial Kir2.x channels also participate (together with other mediators) in a quick increase in the local cerebral blood flow due to neuronal activity (neurovascular coupling) in the brain arteries [31, 58, 161]. The neuronal action potential is accompanied by an increase in the perivascular K+ concentration [92]. This perivascular K+ elevation leads to endothelial Kir channel activation in the capillaries, membrane hyperpolarization, and vasodilatation [10, 49, 161] and subsequent retrograde vasodilatory signal propagation [136]. The neurovascular coupling is complex and includes not only the neurons and endothelial cells, but also the astrocytes [99] and pericytes [81] in the vicinity. Moreover, the active neurons could release not only K+ but also a mediator, possibly PGE2 [138]. If it is so, activation of PGE2 receptors and the downstream cascade follow with the subsequent IP3R-mediated signaling and increase in endothelial [Ca2+]c.

K+ ions and MEGJ in endothelium-dependent hyperpolarization

The K+ ions are effluxed by the endothelial IKCa and SKCa channels [70] which are activated by an increase in endothelial [Ca2+]c. Increase in extracellular K+ ion concentration in the proximity of the neighboring VSM cell activates the Na+/K+ ATPases together with the Kir channels (amplification of the IKCa- and SKCa-initiated hyperpolarization), and subsequently results in a decrease of membrane potential (more negative). The calcium-sensing receptors (CaSR) might secure the activity of the endothelial KCa channels only within a certain range of [Ca2+]c, while Ca2+ concentration above a certain threshold (~ 1 mM) causes their inhibition [25]. It is noteworthy that a pronounced increase in extracellular K+ (above ~ 20 mM) induces vasoconstriction. The participation of CaSR in EDH is not generally accepted and may play a role only in some vascular beds and states. In the rabbit mesenteric arteries, this vasodilatation was endothelium-dependent with increased NO production and IKCa channel activation [78]. In the male rat mesenteric arteries, the CaSR on the perivascular sensory nerves mediated vasodilatation, which involved both endothelium-dependent and endothelium-independent mechanisms, and a role of the calcitonin gene-related peptide and neutrokinin 1 receptors was reported [26]. Importantly, in addition to the endothelial IKCa and SKCa channel activation and subsequent hyperpolarization, the increase in endothelial [Ca2+]c will also trigger production and release of vasodilatory factors such as NO, H2O2, PGI2, and EETs, which will also mediate vasodilatation of the adjacent SMC.

The EDH is also transmitted directly by the gap junctions with bidirectional transfer of the membrane potential (and possibly of small molecules and ions). The MEGJ are composed of connexin proteins forming a hexameric hemichannel. Among the connexins, the Cx40 could play a crucial role in EDH conduction longitudinally along the vessel wall [208]. The impact of K+ ions and the gap junctions varies according to the vessel type. As the number of MEJGs increases with decreasing arterial diameter [197], the contribution of MEGJ to EHD in small vessels is probably more significant. The role of mediator (Ca2+, IP3) transfer through the gap junctions between adjacent endothelial cells (EEGJs) is not clear, but there are some studies supporting this [68, 95, 227].

Radial and axial transmission of EDH

The endothelial KCa channels and the gap junctions that are located towards the neighboring VSM cells allow radial propagation of EDH and induction of vasodilatation. The KCa channels and the gap junctions which are located towards the neighboring endothelial cells are equally important, since they mediate the axial propagation of the initially local vasodilatation along the vessel [44, 102, 103]. There are two types of the endothelial KCa channels with different localization [45, 198]. The localization is highly variable within and between beds and states. The IKCa channels are abundant at some MEGJ, and are also located over the surface of the endothelium. The SKCa are concentrated towards the adjacent endothelial cells, but these channels are also over the surface of the endothelium. Different roles of both channel types are supported by their different status in hypertension, where the function/expression of the IKCa channels is enhanced [73, 198] while that of the SKCa channels suppressed [118, 201, 241]. In certain vessels (observed ex vivo in rat middle cerebral artery), the activation of the SKCa channels may be important for NO-dependent vasodilatation, whereas that of the IKCa channels for the NO-independent mode (in the absence of NO, IKCa underpined endothelium-dependent hyperpolarization and relaxation) [150].

For EDH, the co-localization of all the important structures (the KCa channels, CaSR, Na+/K+ ATPase, Kir channels, IP3R) in the proximity of the gap junctions is optimal. At least partially, they could be anchored to the plasma membrane by the AKAP150 as the scaffolding protein. The TRPV4 channels are present in the same cluster [212]. These channels not only secure the spontaneous Ca2+ sparklets but can also be activated by the agonist of GPCR of the Gq type with the activation of the IP3 + DAG/PKC/AKAP/TRPV4 pathway. Besides, the TRPV4 channels probably also work as the shear stress sensors [228]. In this way, the endothelium at least partially mediates the physiological autoregulatory response to pressure changes [87]. The activity of the endothelial TRPV4 channels is impaired under cardiovascular diseases [33]. Surprisingly, their upregulation was reported in the hypertension induced by high sodium intake [66], which could be explained by a compensatory mechanism. Other endothelial TRP channels also participate in endothelial vasodilatation [50]. For example, the TRPA1 channels are involved in the sensing of extremely wide variety of stimuli (chemical, thermal, and mechanical, including stretch sensitivity) [219, 228]. Accordingly, the endothelium-dependent artery dilatation mediated by the TRPA1 and KCa channels was reported on isolated pressurized rat cerebral arteries [51]. In addition, various TRP channels participate in endothelial the store-operated extracellular Ca2+ entry (SOCE) and thus indirectly influence EDH; however, the endothelial SOCE can also be independent of them [223]. The chloride channels are important for the physiological EDH as well. Upon activation, these channels give rise to depolarization, and their upregulation counteracts the EDH [76, 140].

Last but not the least, the IKCa- and SKCa- hyperpolarization was well demonstrated ex vivo. In vivo experiments demonstrated electrical coupling between endothelium and VSM cells, but the tight myoendothelial coupling remains not clearly confirmed [41], and might be only activated under special (pathological?) conditions [208]. Analogous doubts exist about the crucial role of the connexin Cx40 in EDH signaling under in vivo conditions [18, 209]. Possible explanation could lie in the different size of the vessels studied in ex vivo (in general, vessels > 100 μm) and in vivo (smaller vessels studied with intravital microscopy) experiments [208]. It is noteworthy that it is the microcirculation that determines the vascular resistance. The EDH is summarized in Fig. 7.

Fig. 7.

Fig. 7

The role of the endothelium-dependent hyperpolarization (EDH) in the relaxation of the vascular smooth muscle (VSM) cells. A decrease in the membrane potential of endothelial cells (EC) gives rise to vasodilatation. The conduction of the hyperpolarization from ECs to VSM cells is mediated by the K+ ions and the myoendothelial gap junctions (MEGJ). First, an increase of the cytosolic calcium concentration in ECs, either through the spontaneous opening of the transient receptor potential cation channels (TRPV4 and TRPC), allowing the influx of calcium from the extracellular space, or via its release from the sarcoplasmic reticulum (SR) through the inositol trisphosphate receptors (IP3R), gives rise to the activation of the endothelial small-conductance and intermediate-conductance calcium-activated K+ channels, IKCa and SKCa, respectively. Opening of KCa channels brings about the efflux of K+ ions and the activation of the Na+/K+-ATPase as well as the activation of the inward-rectifier K+ (Kir) channels resulting in the decrease of the VSM cell membrane potential. The calcium-sensing receptors (CaSR) neighboring on KCa are responsible for tuning the activity of the KCa channels only within the range of the cytosolic calcium [Ca2+]c, up to ~ 1 mM, the concentration at which their inhibition takes place. The conduction of the hyperpolarization is also enabled by the MEGJ. Apparently, there is an inverse relationship between the vessel size and the number of the MEGJ; i.e., smaller vessels are richer in the MEGJ. The hyperpolarization of the VSM cells inhibits the Cav1.2 (L-type) calcium channels and promotes VSM cell relaxation.

Other abbreviations: CICR, calcium-induced calcium-release; EEGJ, gap junctions between adjacent endothelial cells; Na+/K+-ATPase, sodium/potassium ATPase

Vasodilatory stimuli

The endothelium and the VSM cells are exposed to a large variety of vasoactive stimuli, both vasodilatory and vasoconstrictive. The vasoactive stimuli can be divided into physical (subcategorized as mechanical or thermal ) and chemical. For the vascular response, the resulting changes in the membrane potential and the traffic of Ca2+ ions are decisive. As mentioned above, the vasodilatation is promoted by the [Ca2+]c decrease in the VSM cells and its increase in the endothelial cells, and also by the membrane hyperpolarization in both.

Mechanical stimuli

The mechanical stimulation is always active even under the resting conditions as a result of the blood flow and physiological blood pressure. The fluid shear stress and pulsatile stretch of the vascular wall continuously stimulate NO production with vasodilatation and prevent the transcription of the atherogenic factors. NO production decreases when the blood flow velocity decreases and when the laminar flow becomes turbulent [35, 235]. The receptors for angiotensin II are involved in the detection of the mechanical stimuli through the activation of the GPCR of the Gq type and the PLC/IP3 + DAG pathway. There is a vast amount of literature data on AT1a receptors [151], which dominates in the vasculature, but some reports on AT2 have also been released [14].

The mechanism of the physiological blood flow-mediated vasodilatation is complex. The blood-flow-induced shear stress induces eNOS expression and subsequent NO release [190, 245]. The stress also induces posttranslational phosphorylation of eNOS [91] and triggers the autocrine production of bradykinin. The latter stimulates further release of NO [80] through the GPCR of the Gq type, and this effect may be governed by the activation of the AT2 receptors in some vascular beds, as reported for the rat carotid artery [14]. Increased blood flow due to physical activity also results in upregulation of eNOS and vasodilatation. Regular exercise is generally regarded as beneficial for the endothelial function and cardiovascular system [169, 222]. In response to elevated shear stress, the endothelial TRPV4 [152], IKCa, and SKCa [218] channels open, which indicates an increase in endothelial [Ca2+]c. The epoxygenases of the CYP2C family and the production of prostacyclin are involved as well. Noteworthy, the CYP2C9 is, in addition, linked to the blood flow-induced-vasodilatation which is NO- and prostacyclin-independent [59].

Thermal stimuli

In general, temperature rise or its mild decrease induce vasodilatation. Various TRP channels are thought to be temperature-sensitive. The TRPC5 channels are highly sensitive to the temperature range of 37–25 °C. Out of the physiological range, the TRPV1 channels open near 40 °C and the TRPV2 channels are activated at temperatures higher than 50 °C.

Accordingly, a mild hypothermia of dog vessels resulted in vasodilatation with the release of endothelial PGI2 and NO and involvement of the muscarinic M1 receptors. The latter indicates a local release of acetylcholine. Vasodilatation involving acetylcholine may become more important under hypertension, and possibly also under other pathological conditions [55, 264]. In contrast, a vasoconstrictive response is initiated once the temperature drops below approximately 30 °C. In these cases, the role of endothelium is minor or lacking [55].

Chemical stimuli

Chemical stimuli can act on endothelium, on VSM or both sites. These stimuli can target both intracellular and plasma membrane structures, principally the GPCR or the ion channels. In the case of GPCR, vasodilatation can be triggered by the activation of the endothelial Gq, Gs, and Gi receptors and the Gs receptors of the smooth muscle. Acetylcholin (muscarinic receptors), bradykinin (B2 receptors), histamin (H1 receptors), substance P (NK1 receptors), and 17β-estradiol (membrane G protein-coupled estrogen receptors GPER) [183, 184, 332, 333] can serve as examples of Gq agonists. Examples of endothelial agonists at Gs receptors are agonists of β2 receptors, PGE2 (EP2 receptors), and vasopressin (V2 receptors). Finally, ET-1 (ETB receptors), agonists of α2 receptors, and serotonin (cerebral 5-HT1 receptors) can be given as examples of the endothelial Gi agonists [113, 235]. In contrast, the activation of the endothelial G12/13 and the smooth muscle Gq, Gi, and G12/13 receptors results in vasoconstriction. As indicated above, the same receptor types can be located on the endothelium, the smooth muscle, or both sites. For example, the muscarinic M3 receptors (Gq) can be found on both the endothelium and the smooth muscle. Acetylcholine induces dose-dependent vasodilatation only when a functional endothelium is present. If not, acetylcholine in low doses has no effect or gives rise to vasoconstriction in high doses. This is widely used as a test of endothelial integrity in ex vivo experiments. The concentration achieved represents another important factor. Thus, acetylcholine can act on endothelial M3 receptors at lower concentrations and result in a dilatation, while at higher concentrations, M1(?) receptors on VSM are activated resulting in a vasoconstriction.

The effect of a substance may be mediated by multiple receptor types and, in addition, these receptors may be linked to multiple signaling pathways. The complexity of the vasoactive action can be demonstrated on 5-HT. Serotonin has 5-HT1, 5-HT2 a 5-HT7 vascular receptors. At doses > ~ 1 nM (in ex vivo experiments) and under pathological conditions, the substance displays vasoconstrictive effects by the direct action on the muscular 5-HT2 (Gq) receptors. In the CNS, the 5-HT1 (Gi) receptors participate in a similar way (notably, triptan-mediated vasoconstriction in migraine treatment is the result of their activation) [233]. In contrast, at low concentrations and under physiological conditions, 5-HT gives rise to vasodilatation via the endothelial 5-HT2 (Gq) receptors; the 5-HT7 (Gs) receptors may also be involved.

Other vasodilatory substances influence the membrane ion channels directly (e.g., a blocker of Cav1.2 channels, nifedipine) or target the intracellular signaling cascades, such as cyclases (an activator of adenylate cyclase, forskolin, or of soluble guanylate cyclase, riociguat), protein kinases (an inhibitor of PKC, ruboxistaurin, or of ROCK, fasudil), phosphodiesterases (an inhibitor of PDE3, cilostazol, or of PDE5, sildenafil), ion channels on the SR (an inhibitor of RyR channels, dantrolene), SERCA (an activator, CDN1163), or specific proteins, such as caveolin-1 (binding of cavnoxin results in maintaining the eNOS active).

To date, a number of vasoactive substances are known. Endogenous substances, such as neurotransmitters, hormones, ions, and small gasotransmitters, act as important signaling molecules. The family of exogenous substances ranges from toxins to clinically used drugs. New structures and their targets are constantly being discovered, sometimes unexpectedly, such as vascular bitter taste receptors and their ligands [32, 144].

Conclusions

Adequate blood supply according to immediate needs is secured by a delicate balance between vasodilatation and vasoconstriction. Imbalance in one (or both) can result in a dysfunction or even a disease. As detailed in this review, the vascular homeostasis is regulated by a plethora of mechanisms, which complement each other and can, if necessary, partially substitute each other. The overall interplay of all participants still remains not fully understood, and deserves further attention.

Author contribution

J.P. designed and drafted manuscript, prepared graphical abstract and approved the final version, P.D. prepared figures and graphical abstract, M.P. made critical comments on chemical aspects, P.M. made critical comments on pharmacological aspects.

Funding

Open access publishing supported by the institutions participating in the CzechELib Transformative Agreement. The authors thank the Czech Research Health Council (project NU21-02-00135) and Charles University (grant GAUK 236923).

Data Availability

No datasets were generated or analysed during the current study.

Declarations

Ethical approval and consent to participate

Not applicable.

Human ethics

Not applicable.

Consent for publication

All authors have approved the submission.

Competing interests

The authors declare no competing interests.

Clinical trial number

Not applicable.

Footnotes

The original online version of this article was revised: In the original version of the manuscript, there are 9 incorrect cross references located at page 2, 8, 9, 11, and 12. This should be corrected as the identification of sections is important because it is used in cross-references and the clarity of the article would be significantly increased and the text would be more reader-friendly

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Change history

6/21/2025

The original online version of this article was revised: In the original version of the manuscript, there are 9 incorrect cross references located at page 2, 8, 9, 11, and 12. This should be corrected as the identification of sections is important because it is used in cross-references and the clarity of the article would be significantly increased and the text would be more reader-friendly

Change history

6/20/2025

A Correction to this paper has been published: 10.1007/s00424-025-03102-7

References

  • 1.Abbink EJ, Walker AJ, van der Sluijs HA, Tack CJ, Smits P (2002) No role of calcium- and ATP-dependent potassium channels in insulin-induced vasodilation in humans in vivo. Diabetes Metab Res Rev 18:143–148. 10.1002/dmrr.269 [DOI] [PubMed] [Google Scholar]
  • 2.Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schöneich C, Cohen RA (2004) S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med 10:1200–1207. 10.1038/nm1119 [DOI] [PubMed] [Google Scholar]
  • 3.Ahn SJ, Fancher IS, Bian JT, Zhang CX, Schwab S, Gaffin R, Phillips SA, Levitan I (2017) Inwardly rectifying K(+) channels are major contributors to flow-induced vasodilatation in resistance arteries. J Physiol 595:2339–2364. 10.1113/jp273255 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ahn SJ, Fancher IS, Granados ST, Do Couto NF, Hwang CL, Phillips SA, Levitan I (2022) Cholesterol-induced suppression of endothelial Kir channels is a driver of impairment of arteriolar flow-induced vasodilation in humans. Hypertension 79:126–138. 10.1161/hypertensionaha.121.17672 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Alderton WK, Cooper CE, Knowles RG (2001) Nitric oxide synthases: structure, function and inhibition. Biochem J 357:593–615. 10.1042/0264-6021:3570593 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Arnal JF, Fontaine C, Billon-Galés A, Favre J, Laurell H, Lenfant F, Gourdy P (2010) Estrogen receptors and endothelium. Arterioscler Thromb Vasc Biol 30:1506–1512. 10.1161/atvbaha.109.191221 [DOI] [PubMed] [Google Scholar]
  • 7.Arnaudeau S, Macrez-Leprêtre N, Mironneau J (1996) Activation of calcium sparks by angiotensin II in vascular myocytes. Biochem Biophys Res Commun 222:809–815. 10.1006/bbrc.1996.0808 [DOI] [PubMed] [Google Scholar]
  • 8.Arora S, Veves A, Caballaro AE, Smakowski P, LoGerfo FW (1998) Estrogen improves endothelial function. J Vasc Surg 27:1141–1146; discussion 1147. 10.1016/s0741-5214(98)70016-3 [DOI] [PubMed]
  • 9.Askew Page HR, Dalsgaard T, Baldwin SN, Jepps TA, Povstyan O, Olesen SP, Greenwood IA (2019) TMEM16A is implicated in the regulation of coronary flow and is altered in hypertension. Br J Pharmacol 176:1635–1648. 10.1111/bph.14598 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA (2010) Glial and neuronal control of brain blood flow. Nature 468:232–243. 10.1038/nature09613 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Averna M, Stifanese R, De Tullio R, Passalacqua M, Salamino F, Pontremoli S, Melloni E (2008) Functional role of HSP90 complexes with endothelial nitric-oxide synthase (eNOS) and calpain on nitric oxide generation in endothelial cells. J Biol Chem 283:29069–29076. 10.1074/jbc.M803638200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bagher P, Beleznai T, Kansui Y, Mitchell R, Garland CJ, Dora KA (2012) Low intravascular pressure activates endothelial cell TRPV4 channels, local Ca2+ events, and IKCa channels, reducing arteriolar tone. Proc Natl Acad Sci U S A 109:18174–18179. 10.1073/pnas.1211946109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.BelAiba RS, Djordjevic T, Petry A, Diemer K, Bonello S, Banfi B, Hess J, Pogrebniak A, Bickel C, Görlach A (2007) NOX5 variants are functionally active in endothelial cells. Free Radic Biol Med 42:446–459. 10.1016/j.freeradbiomed.2006.10.054 [DOI] [PubMed] [Google Scholar]
  • 14.Bergaya S, Hilgers RH, Meneton P, Dong Y, Bloch-Faure M, Inagami T, Alhenc-Gelas F, Lévy BI, Boulanger CM (2004) Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors. Circ Res 94:1623–1629. 10.1161/01.RES.0000131497.73744.1a [DOI] [PubMed] [Google Scholar]
  • 15.Berna-Erro A, Izquierdo-Serra M, Sepúlveda RV, Rubio-Moscardo F, Doñate-Macián P, Serra SA, Carrillo-Garcia J, Perálvarez-Marín A, González-Nilo F, Fernández-Fernández JM, Valverde MA (2017) Structural determinants of 5′,6′-epoxyeicosatrienoic acid binding to and activation of TRPV4 channel. Sci Rep 7:10522. 10.1038/s41598-017-11274-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Billecke SS, Bender AT, Kanelakis KC, Murphy PJ, Lowe ER, Kamada Y, Pratt WB, Osawa Y (2002) hsp90 is required for heme binding and activation of apo-neuronal nitric-oxide synthase: geldanamycin-mediated oxidant generation is unrelated to any action of hsp90. J Biol Chem 277:20504–20509. 10.1074/jbc.M201940200 [DOI] [PubMed] [Google Scholar]
  • 17.Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297:842–857. 10.1001/jama.297.8.842 [DOI] [PubMed] [Google Scholar]
  • 18.Boettcher M, de Wit C (2011) Distinct endothelium-derived hyperpolarizing factors emerge in vitro and in vivo and are mediated in part via connexin 40-dependent myoendothelial coupling. Hypertension 57:802–808. 10.1161/hypertensionaha.110.165894 [DOI] [PubMed] [Google Scholar]
  • 19.Boo YC, Sorescu G, Boyd N, Shiojima I, Walsh K, Du J, Jo H (2002) Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms: role of protein kinase A. J Biol Chem 277:3388–3396. 10.1074/jbc.M108789200 [DOI] [PubMed] [Google Scholar]
  • 20.Bourmeyster N, Vignais PV (1996) Phosphorylation of Rho GDI stabilizes the Rho A-Rho GDI complex in neutrophil cytosol. Biochem Biophys Res Commun 218:54–60. 10.1006/bbrc.1996.0011 [DOI] [PubMed] [Google Scholar]
  • 21.Bourque SL, Davidge ST, Adams MA (2011) The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 300:R1288–R1295. 10.1152/ajpregu.00397.2010 [DOI] [PubMed] [Google Scholar]
  • 22.Bubb KJ, Birgisdottir AB, Tang O, Hansen T, Figtree GA (2017) Redox modification of caveolar proteins in the cardiovascular system- role in cellular signalling and disease. Free Radic Biol Med 109:61–74. 10.1016/j.freeradbiomed.2017.02.012 [DOI] [PubMed] [Google Scholar]
  • 23.Campbell WB, Fleming I (2010) Epoxyeicosatrienoic acids and endothelium-dependent responses. Pflugers Arch 459:881–895. 10.1007/s00424-010-0804-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Campbell WB, Gauthier KM (2013) Inducible endothelium-derived hyperpolarizing factor: role of the 15-lipoxygenase-EDHF pathway. J Cardiovasc Pharmacol 61:176–187.10.1097/FJC.0b013e31828165db [DOI] [PMC free article] [PubMed]
  • 25.Carlton-Carew SRE, Greenberg HZE, Connor EJ, Zadeh P, Greenwood IA, Albert AP (2024) Stimulation of the calcium-sensing receptor induces relaxations of rat mesenteric arteries by endothelium-dependent and -independent pathways via BK(Ca) and K(ATP) channels. Physiol Rep 12:e15926. 10.14814/phy2.15926 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Carlton-Carew SRE, Greenberg HZE, Greenwood IA, Albert AP (2024) Stimulation of the calcium-sensing receptor induces relaxations through CGRP and NK1 receptor-mediated pathways in male rat mesenteric arteries. Physiol Rep 12:e16125. 10.14814/phy2.16125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Castello PR, David PS, McClure T, Crook Z, Poyton RO (2006) Mitochondrial cytochrome oxidase produces nitric oxide under hypoxic conditions: implications for oxygen sensing and hypoxic signaling in eukaryotes. Cell Metab 3:277–287. 10.1016/j.cmet.2006.02.011 [DOI] [PubMed] [Google Scholar]
  • 28.Cil O, Chen X, Askew Page HR, Baldwin SN, Jordan MC, Myat Thwe P, Anderson MO, Haggie PM, Greenwood IA, Roos KP, Verkman AS (2021) A small molecule inhibitor of the chloride channel TMEM16A blocks vascular smooth muscle contraction and lowers blood pressure in spontaneously hypertensive rats. Kidney Int. 10.1016/j.kint.2021.03.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Cipolla MJ, Gokina NI, Osol G (2002) Pressure-induced actin polymerization in vascular smooth muscle as a mechanism underlying myogenic behavior. Faseb j 16:72–76. 10.1096/cj.01-0104hyp [DOI] [PubMed] [Google Scholar]
  • 30.Chauhan SD, Nilsson H, Ahluwalia A, Hobbs AJ (2003) Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc Natl Acad Sci U S A 100:1426–1431. 10.1073/pnas.0336365100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Chen BR, Kozberg MG, Bouchard MB, Shaik MA, Hillman EM (2014) A critical role for the vascular endothelium in functional neurovascular coupling in the brain. J Am Heart Assoc 3:e000787. 10.1161/jaha.114.000787 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Chen JG, Ping NN, Liang D, Li MY, Mi YN, Li S, Cao L, Cai Y, Cao YX (2017) The expression of bitter taste receptors in mesenteric, cerebral and omental arteries. Life Sci 170:16–24. 10.1016/j.lfs.2016.11.010 [DOI] [PubMed] [Google Scholar]
  • 33.Chen YL, Sonkusare SK (2020) Endothelial TRPV4 channels and vasodilator reactivity. Curr Top Membr 85:89–117. 10.1016/bs.ctm.2020.01.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, Kemp BE (1999) AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443:285–289. 10.1016/s0014-5793(98)01705-0 [DOI] [PubMed] [Google Scholar]
  • 35.Chiu JJ, Chien S (2011) Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev 91:327–387. 10.1152/physrev.00047.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Colyer J (1998) Phosphorylation states of phospholamban. Ann N Y Acad Sci 853:79–91. 10.1111/j.1749-6632.1998.tb08258.x [DOI] [PubMed] [Google Scholar]
  • 37.Constantin B (2014) Dystrophin complex functions as a scaffold for signalling proteins. Biochim Biophys Acta 1838:635–642. 10.1016/j.bbamem.2013.08.023 [DOI] [PubMed] [Google Scholar]
  • 38.Conti MA, Adelstein RS (1981) The relationship between calmodulin binding and phosphorylation of smooth muscle myosin kinase by the catalytic subunit of 3′:5′ cAMP-dependent protein kinase. J Biol Chem 256:3178–3181 [PubMed] [Google Scholar]
  • 39.Costa TJ, Barros PR, Arce C, Santos JD, da Silva-Neto J, Egea G, Dantas AP, Tostes RC, Jiménez-Altayó F (2021) The homeostatic role of hydrogen peroxide, superoxide anion and nitric oxide in the vasculature. Free Radical Biol Med 162:615–635. 10.1016/j.freeradbiomed.2020.11.021 [DOI] [PubMed] [Google Scholar]
  • 40.Dalkara T, Østergaard L, Heusch G, Attwell D (2025) Pericytes in the brain and heart: functional roles and response to ischaemia and reperfusion. Cardiovasc Res 120:2336–2348. 10.1093/cvr/cvae147 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.de Wit C, Boettcher M, Schmidt VJ (2008) Signaling across myoendothelial gap junctions–fact or fiction? Cell Commun Adhes 15:231–245. 10.1080/15419060802440260 [DOI] [PubMed] [Google Scholar]
  • 42.Dias P, Pourová J, Vopršalová M, Nejmanová I, Mladěnka P (2022) 3-Hydroxyphenylacetic acid: a blood pressure-reducing flavonoid metabolite. Nutrients 14. 10.3390/nu14020328 [DOI] [PMC free article] [PubMed]
  • 43.Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601–605. 10.1038/21224 [DOI] [PubMed] [Google Scholar]
  • 44.Dora KA, Damon DN, Duling BR (2000) Microvascular dilation in response to occlusion: a coordinating role for conducted vasomotor responses. Am J Physiol Heart Circ Physiol 279:H279-284. 10.1152/ajpheart.2000.279.1.H279 [DOI] [PubMed] [Google Scholar]
  • 45.Dora KA, Gallagher NT, McNeish A, Garland CJ (2008) Modulation of endothelial cell KCa3.1 channels during endothelium-derived hyperpolarizing factor signaling in mesenteric resistance arteries. Circ Res 102:1247–1255. 10.1161/circresaha.108.172379 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Doseděl M, Jirkovský E, Macáková K, Krčmová LK, Javorská L, Pourová J, Mercolini L, Remião F, Nováková L, Mladěnka P, On Behalf Of The O (2021) Vitamin C-sources, physiological role, kinetics, deficiency, use, toxicity, and determination. Nutrients 13. 10.3390/nu13020615 [DOI] [PMC free article] [PubMed]
  • 47.Dou D, Zheng X, Liu J, Xu X, Ye L, Gao Y (2012) Hydrogen peroxide enhances vasodilatation by increasing dimerization of cGMP-dependent protein kinase type Iα. Circ J 76:1792–1798. 10.1253/circj.cj-11-1368 [DOI] [PubMed] [Google Scholar]
  • 48.Dunaway LS, Mills WA 3rd, Eyo UB, Isakson BE (2025) The cells of the vasculature: advances in the regulation of vascular tone in the brain and periphery. Basic Clin Pharmacol Toxicol 136:e70023. 10.1111/bcpt.70023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Dunn KM, Nelson MT (2010) Potassium channels and neurovascular coupling. Circ J 74:608–616. 10.1253/circj.cj-10-0174 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Earley S, Brayden JE (2015) Transient receptor potential channels in the vasculature. Physiol Rev 95:645–690. 10.1152/physrev.00026.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Earley S, Gonzales AL, Crnich R (2009) Endothelium-dependent cerebral artery dilation mediated by TRPA1 and Ca2+-activated K+ channels. Circ Res 104:987–994. 10.1161/circresaha.108.189530 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Earley S, Pauyo T, Drapp R, Tavares MJ, Liedtke W, Brayden JE (2009) TRPV4-dependent dilation of peripheral resistance arteries influences arterial pressure. Am J Physiol Heart Circ Physiol 297:H1096-1102. 10.1152/ajpheart.00241.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Ehmsen J, Poon E, Davies K (2002) The dystrophin-associated protein complex. J Cell Sci 115:2801–2803. 10.1242/jcs.115.14.2801 [DOI] [PubMed] [Google Scholar]
  • 54.Eroglu E, Saravi SSS, Sorrentino A, Steinhorn B, Michel T (2019) Discordance between eNOS phosphorylation and activation revealed by multispectral imaging and chemogenetic methods. Proc Natl Acad Sci U S A 116:20210–20217. 10.1073/pnas.1910942116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Evora PR, Cable DG, Chua YL, Rodrigues AJ, Pearson PJ, Schaff HV (2007) Nitric oxide and prostacyclin-dependent pathways involvement on in vitro induced hypothermia. Cryobiology 54:106–113. 10.1016/j.cryobiol.2006.12.002 [DOI] [PubMed] [Google Scholar]
  • 56.Fan G, Cui Y, Gollasch M, Kassmann M (2019) Elementary calcium signaling in arterial smooth muscle. Channels (Austin) 13:505–519. 10.1080/19336950.2019.1688910 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Faraci FM, Sobey CG, Chrissobolis S, Lund DD, Heistad DD, Weintraub NL (2001) Arachidonate dilates basilar artery by lipoxygenase-dependent mechanism and activation of K(+) channels. Am J Physiol Regul Integr Comp Physiol 281:R246-253. 10.1152/ajpregu.2001.281.1.R246 [DOI] [PubMed] [Google Scholar]
  • 58.Filosa JA, Bonev AD, Straub SV, Meredith AL, Wilkerson MK, Aldrich RW, Nelson MT (2006) Local potassium signaling couples neuronal activity to vasodilation in the brain. Nat Neurosci 9:1397–1403. 10.1038/nn1779 [DOI] [PubMed] [Google Scholar]
  • 59.Fischer D, Landmesser U, Spiekermann S, Hilfiker-Kleiner D, Hospely M, Müller M, Busse R, Fleming I, Drexler H (2007) Cytochrome P450 2C9 is involved in flow-dependent vasodilation of peripheral conduit arteries in healthy subjects and in patients with chronic heart failure. Eur J Heart Fail 9:770–775. 10.1016/j.ejheart.2007.05.005 [DOI] [PubMed] [Google Scholar]
  • 60.Fisslthaler B, Dimmeler S, Hermann C, Busse R, Fleming I (2000) Phosphorylation and activation of the endothelial nitric oxide synthase by fluid shear stress. Acta Physiol Scand 168:81–88. 10.1046/j.1365-201x.2000.00627.x [DOI] [PubMed] [Google Scholar]
  • 61.Fleming I, Fisslthaler B, Dimmeler S, Kemp BE, Busse R (2001) Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res 88:E68-75. 10.1161/hh1101.092677 [DOI] [PubMed] [Google Scholar]
  • 62.Fontana J, Fulton D, Chen Y, Fairchild TA, McCabe TJ, Fujita N, Tsuruo T, Sessa WC (2002) Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ Res 90:866–873. 10.1161/01.res.0000016837.26733.be [DOI] [PubMed] [Google Scholar]
  • 63.Foote CA, Soares RN, Ramirez-Perez FI, Ghiarone T, Aroor A, Manrique-Acevedo C, Padilla J, Martinez-Lemus L (2022) Endothelial glycocalyx Compr Physiol 12:3781–3811. 10.1002/cphy.c210029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Foskett JK, White C, Cheung KH, Mak DO (2007) Inositol trisphosphate receptor Ca2+ release channels. Physiol Rev 87:593–658. 10.1152/physrev.00035.2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Friederich-Persson M, Nguyen Dinh Cat A, Persson P, Montezano AC, Touyz RM (2017) Brown adipose tissue regulates small artery function through NADPH oxidase 4-derived hydrogen peroxide and redox-sensitive protein kinase G-1α. Arterioscler Thromb Vasc Biol 37:455–465. 10.1161/atvbaha.116.308659 [DOI] [PubMed] [Google Scholar]
  • 66.Gao F, Sui D, Garavito RM, Worden RM, Wang DH (2009) Salt intake augments hypotensive effects of transient receptor potential vanilloid 4: functional significance and implication. Hypertension 53:228–235. 10.1161/hypertensionaha.108.117499 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.García-Redondo AB, Briones AM, Beltrán AE, Alonso MJ, Simonsen U, Salaices M (2009) Hypertension increases contractile responses to hydrogen peroxide in resistance arteries through increased thromboxane A2, Ca2+, and superoxide anion levels. J Pharmacol Exp Ther 328:19–27. 10.1124/jpet.108.144295 [DOI] [PubMed] [Google Scholar]
  • 68.Garland CJ, Bagher P, Powell C, Ye X, Lemmey HAL, Borysova L, Dora KA (2017) Voltage-dependent Ca(2+) entry into smooth muscle during contraction promotes endothelium-mediated feedback vasodilation in arterioles. Sci Signal 10. 10.1126/scisignal.aal3806 [DOI] [PubMed]
  • 69.Garland CJ, Dora KA (2017) EDH: endothelium-dependent hyperpolarization and microvascular signalling. Acta Physiol (Oxf) 219:152–161. 10.1111/apha.12649 [DOI] [PubMed] [Google Scholar]
  • 70.Garland CJ, Hiley CR, Dora KA (2011) EDHF: spreading the influence of the endothelium. Br J Pharmacol 164:839–852. 10.1111/j.1476-5381.2010.01148.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Gauthier KM, Goldman DH, Aggarwal NT, Chawengsub Y, Falck JR, Campbell WB (2011) Role of arachidonic acid lipoxygenase metabolites in acetylcholine-induced relaxations of mouse arteries. Am J Physiol Heart Circ Physiol 300:H725-735. 10.1152/ajpheart.00696.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Geiselhöringer A, Werner M, Sigl K, Smital P, Wörner R, Acheo L, Stieber J, Weinmeister P, Feil R, Feil S, Wegener J, Hofmann F, Schlossmann J (2004) IRAG is essential for relaxation of receptor-triggered smooth muscle contraction by cGMP kinase. Embo j 23:4222–4231. 10.1038/sj.emboj.7600440 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Giachini FR, Carneiro FS, Lima VV, Carneiro ZN, Dorrance A, Webb RC, Tostes RC (2009) Upregulation of intermediate calcium-activated potassium channels counterbalance the impaired endothelium-dependent vasodilation in stroke-prone spontaneously hypertensive rats. Transl Res 154:183–193. 10.1016/j.trsl.2009.07.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Gold MG (2019) Swimming regulations for protein kinase A catalytic subunit. Biochem Soc Trans 47:1355–1366. 10.1042/bst20190230 [DOI] [PubMed] [Google Scholar]
  • 75.Gong MC, Fuglsang A, Alessi D, Kobayashi S, Cohen P, Somlyo AV, Somlyo AP (1992) Arachidonic acid inhibits myosin light chain phosphatase and sensitizes smooth muscle to calcium. J Biol Chem 267:21492–21498 [PubMed] [Google Scholar]
  • 76.Goto K, Edwards FR, Hill CE (2007) Depolarization evoked by acetylcholine in mesenteric arteries of hypertensive rats attenuates endothelium-dependent hyperpolarizing factor. J Hypertens 25:345–359. 10.1097/HJH.0b013e328010d616 [DOI] [PubMed] [Google Scholar]
  • 77.Gratton JP, Fontana J, O’Connor DS, Garcia-Cardena G, McCabe TJ, Sessa WC (2000) Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. J Biol Chem 275:22268–22272. 10.1074/jbc.M001644200 [DOI] [PubMed] [Google Scholar]
  • 78.Greenberg HZ, Shi J, Jahan KS, Martinucci MC, Gilbert SJ, Vanessa Ho WS, Albert AP (2016) Stimulation of calcium-sensing receptors induces endothelium-dependent vasorelaxations via nitric oxide production and activation of IKCa channels. Vascul Pharmacol 80:75–84. 10.1016/j.vph.2016.01.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Grover Páez F, Esparza Pimentel J (2022) Endothelial dysfunction, molecular biology, physiopathology, diagnosis, and treatment. In: Abukabda A, Fonner C (eds) Endothelial Dysfunction - A Novel Paradigm. IntechOpen, Rijeka. 10.5772/intechopen.107481
  • 80.Groves P, Kurz S, Just H, Drexler H (1995) Role of endogenous bradykinin in human coronary vasomotor control. Circulation 92:3424–3430. 10.1161/01.cir.92.12.3424 [DOI] [PubMed] [Google Scholar]
  • 81.Grubb S, Lauritzen M, Aalkjær C (2021) Brain capillary pericytes and neurovascular coupling. Comp Biochem Physiol A: Mol Integr Physiol 254:110893. 10.1016/j.cbpa.2020.110893 [DOI] [PubMed] [Google Scholar]
  • 82.Gudi T, Chen JC, Casteel DE, Seasholtz TM, Boss GR, Pilz RB (2002) cGMP-dependent protein kinase inhibits serum-response element-dependent transcription by inhibiting rho activation and functions. J Biol Chem 277:37382–37393. 10.1074/jbc.M204491200 [DOI] [PubMed] [Google Scholar]
  • 83.Hamabata T, Nakamura T, Tachibana Y, Horikami D, Murata T (2018) 5,6-DiHETE attenuates vascular hyperpermeability by inhibiting Ca(2+) elevation in endothelial cells. J Lipid Res 59:1864–1870. 10.1194/jlr.M085233 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Hammond S, Mathewson AM, Baker PN, Mayhew TM, Dunn WR (2011) Gap junctions and hydrogen peroxide are involved in endothelium-derived hyperpolarising responses to bradykinin in omental arteries and veins isolated from pregnant women. Eur J Pharmacol 668:225–232. 10.1016/j.ejphar.2011.06.050 [DOI] [PubMed] [Google Scholar]
  • 85.Han H, Rosenhouse-Dantsker A, Gnanasambandam R, Epshtein Y, Chen Z, Sachs F, Minshall RD, Levitan I (2014) Silencing of Kir2 channels by caveolin-1: cross-talk with cholesterol. J Physiol 592:4025–4038. 10.1113/jphysiol.2014.273177 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Hansen SB, Tao X, MacKinnon R (2011) Structural basis of PIP2 activation of the classical inward rectifier K+ channel Kir2.2. Nature 477:495–498. 10.1038/nature10370 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Harder DR (1987) Pressure-induced myogenic activation of cat cerebral arteries is dependent on intact endothelium. Circ Res 60:102–107. 10.1161/01.res.60.1.102 [DOI] [PubMed] [Google Scholar]
  • 88.Harraz OF, Abd El-Rahman RR, Bigdely-Shamloo K, Wilson SM, Brett SE, Romero M, Gonzales AL, Earley S, Vigmond EJ, Nygren A, Menon BK, Mufti RE, Watson T, Starreveld Y, Furstenhaupt T, Muellerleile PR, Kurjiaka DT, Kyle BD, Braun AP, Welsh DG (2014) Ca(V)3.2 channels and the induction of negative feedback in cerebral arteries. Circ Res 115:650–661. 10.1161/circresaha.114.304056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Harraz OF, Visser F, Brett SE, Goldman D, Zechariah A, Hashad AM, Menon BK, Watson T, Starreveld Y, Welsh DG (2015) CaV1.2/CaV3.x channels mediate divergent vasomotor responses in human cerebral arteries. J Gen Physiol 145:405–418. 10.1085/jgp.201511361 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Haselden WD, Kedarasetti RT, Drew PJ (2020) Spatial and temporal patterns of nitric oxide diffusion and degradation drive emergent cerebrovascular dynamics. PLoS Comput Biol 16:e1008069. 10.1371/journal.pcbi.1008069 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Heiss EH, Dirsch VM (2014) Regulation of eNOS enzyme activity by posttranslational modification. Curr Pharm Des 20:3503–3513. 10.2174/13816128113196660745 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Hodgkin AL, Huxley AF (1952) A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol 117:500–544. 10.1113/jphysiol.1952.sp004764 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Hoffmann LS, Larson CJ, Pfeifer A (2016) cGMP and brown adipose tissue. Handb Exp Pharmacol 233:283–299. 10.1007/164_2015_3 [DOI] [PubMed] [Google Scholar]
  • 94.Hofmann F, Wegener JW (2013) cGMP-dependent protein kinases (cGK). Methods Mol Biol 1020:17–50. 10.1007/978-1-62703-459-3_2 [DOI] [PubMed] [Google Scholar]
  • 95.Hong K, Cope EL, DeLalio LJ, Marziano C, Isakson BE, Sonkusare SK (2018) TRPV4 (transient receptor potential vanilloid 4) channel-dependent negative feedback mechanism regulates G(q) protein-coupled receptor-induced vasoconstriction. Arterioscler Thromb Vasc Biol 38:542–554. 10.1161/atvbaha.117.310038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Huang Z, Shiva S, Kim-Shapiro DB, Patel RP, Ringwood LA, Irby CE, Huang KT, Ho C, Hogg N, Schechter AN, Gladwin MT (2005) Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest 115:2099–2107. 10.1172/jci24650 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Hügel HM, Jackson N, May B, Zhang AL, Xue CC (2016) Polyphenol protection and treatment of hypertension. Phytomedicine 23:220–231. 10.1016/j.phymed.2015.12.012 [DOI] [PubMed] [Google Scholar]
  • 98.Imig JD (2020) Eicosanoid blood vessel regulation in physiological and pathological states. Clin Sci (Lond) 134:2707–2727. 10.1042/cs20191209 [DOI] [PubMed] [Google Scholar]
  • 99.Institoris A, Vandal M, Peringod G, Catalano C, Tran CH, Yu X, Visser F, Breiteneder C, Molina L, Khakh BS, Nguyen MD, Thompson RJ, Gordon GR (2022) Astrocytes amplify neurovascular coupling to sustained activation of neocortex in awake mice. Nat Commun 13:7872. 10.1038/s41467-022-35383-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Isakson BE, Ramos SI, Duling BR (2007) Ca2+ and inositol 1,4,5-trisphosphate-mediated signaling across the myoendothelial junction. Circ Res 100:246–254. 10.1161/01.Res.0000257744.23795.93 [DOI] [PubMed] [Google Scholar]
  • 101.Jackson WF (2000) Ion channels and vascular tone. Hypertension 35:173–178. 10.1161/01.hyp.35.1.173 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Jackson WF (2020) Introduction to ion channels and calcium signaling in the microcirculation. Curr Top Membr 85:1–18. 10.1016/bs.ctm.2020.01.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Jackson WF (2022) Endothelial ion channels and cell-cell communication in the microcirculation. Front Physiol 13:805149. 10.3389/fphys.2022.805149 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Jaggar JH, Li A, Parfenova H, Liu J, Umstot ES, Dopico AM, Leffler CW (2005) Heme is a carbon monoxide receptor for large-conductance Ca2+-activated K+ channels. Circ Res 97:805–812. 10.1161/01.RES.0000186180.47148.7b [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Jaggar JH, Porter VA, Lederer WJ, Nelson MT (2000) Calcium sparks in smooth muscle. Am J Physiol Cell Physiol 278:C235-256. 10.1152/ajpcell.2000.278.2.C235 [DOI] [PubMed] [Google Scholar]
  • 106.Jani MS, Zou J, Veetil AT, Krishnan Y (2020) A DNA-based fluorescent probe maps NOS3 activity with subcellular spatial resolution. Nat Chem Biol 16:660–666. 10.1038/s41589-020-0491-3 [DOI] [PubMed] [Google Scholar]
  • 107.Jung SB, Kim CS, Naqvi A, Yamamori T, Mattagajasingh I, Hoffman TA, Cole MP, Kumar A, Dericco JS, Jeon BH, Irani K (2010) Histone deacetylase 3 antagonizes aspirin-stimulated endothelial nitric oxide production by reversing aspirin-induced lysine acetylation of endothelial nitric oxide synthase. Circ Res 107:877–887. 10.1161/circresaha.110.222968 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Kanagy NL, Szabo C, Papapetropoulos A (2017) Vascular biology of hydrogen sulfide. Am J Physiol Cell Physiol 312:C537-c549. 10.1152/ajpcell.00329.2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Kaßmann M, Szijártó IA, García-Prieto CF, Fan G, Schleifenbaum J, Anistan YM, Tabeling C, Shi Y, le Noble F, Witzenrath M, Huang Y, Markó L, Nelson MT, Gollasch M (2019) Role of ryanodine type 2 receptors in elementary Ca(2+) signaling in arteries and vascular adaptive responses. J Am Heart Assoc 8:e010090. 10.1161/jaha.118.010090 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Kawka DW, Ouellet M, Hétu PO, Singer II, Riendeau D (2007) Double-label expression studies of prostacyclin synthase, thromboxane synthase and COX isoforms in normal aortic endothelium. Biochim Biophys Acta 1771:45–54. 10.1016/j.bbalip.2006.09.015 [DOI] [PubMed] [Google Scholar]
  • 111.Kenworthy AK, Han B, Ariotti N, Parton RG (2023) The role of membrane lipids in the formation and function of caveolae. Cold Spring Harb Perspect Biol 15. 10.1101/cshperspect.a041413 [DOI] [PMC free article] [PubMed]
  • 112.Keserü B, Barbosa-Sicard E, Popp R, Fisslthaler B, Dietrich A, Gudermann T, Hammock BD, Falck JR, Weissmann N, Busse R, Fleming I (2008) Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response. Faseb j 22:4306–4315. 10.1096/fj.08-112821 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Khaddaj Mallat R, Mathew John C, Kendrick DJ, Braun AP (2017) The vascular endothelium: a regulator of arterial tone and interface for the immune system. Crit Rev Clin Lab Sci 54:458–470. 10.1080/10408363.2017.1394267 [DOI] [PubMed] [Google Scholar]
  • 114.Kitazawa T, Semba S, Huh YH, Kitazawa K, Eto M (2009) Nitric oxide-induced biphasic mechanism of vascular relaxation via dephosphorylation of CPI-17 and MYPT1. J Physiol 587:3587–3603. 10.1113/jphysiol.2009.172189 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Knape MJ, Ahuja LG, Bertinetti D, Burghardt NC, Zimmermann B, Taylor SS, Herberg FW (2015) Divalent metal ions Mg2⁺ and Ca2⁺ have distinct effects on protein kinase A activity and regulation. ACS Chem Biol 10:2303–2315. 10.1021/acschembio.5b00271 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Knorr M, Hausding M, Kröller-Schuhmacher S, Steven S, Oelze M, Heeren T, Scholz A, Gori T, Wenzel P, Schulz E, Daiber A, Münzel T (2011) Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan. Arterioscler Thromb Vasc Biol 31:2223–2231. 10.1161/atvbaha.111.232058 [DOI] [PubMed] [Google Scholar]
  • 117.Ko EA, Han J, Jung ID, Park WS (2008) Physiological roles of K+ channels in vascular smooth muscle cells. J Smooth Muscle Res 44:65–81. 10.1540/jsmr.44.65 [DOI] [PubMed] [Google Scholar]
  • 118.Kong BW, Man RY, Gao Y, Vanhoutte PM, Leung SW (2015) Reduced activity of SKC a and Na-K ATPase underlies the accelerated impairment of EDH-type relaxations in mesenteric arteries of aging spontaneously hypertensive rats. Pharmacol Res Perspect 3:e00150. 10.1002/prp2.150 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Kovacevic I, Müller M, Kojonazarov B, Ehrke A, Randriamboavonjy V, Kohlstedt K, Hindemith T, Schermuly RT, Fleming I, Hoffmeister M, Oess S (2015) The F-BAR protein NOSTRIN dictates the localization of the muscarinic M3 receptor and regulates cardiovascular function. Circ Res 117:460–469. 10.1161/circresaha.115.306187 [DOI] [PubMed] [Google Scholar]
  • 120.Kuhn M (2003) Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. Circ Res 93:700–709. 10.1161/01.Res.0000094745.28948.4d [DOI] [PubMed] [Google Scholar]
  • 121.Kuo C-HCC-Y (2016) Characterization of human aortic endothelial cells, endothelial progenitor cells, and cardiomyocytes. J Tradit Med Clin Natur 6. 10.4172/2573-4555.1000203
  • 122.Kutz JL, Greaney JL, Santhanam L, Alexander LM (2015) Evidence for a functional vasodilatatory role for hydrogen sulphide in the human cutaneous microvasculature. J Physiol 593:2121–2129. 10.1113/jp270054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Kwan HY, Shen B, Ma X, Kwok YC, Huang Y, Man YB, Yu S, Yao X (2009) TRPC1 associates with BK(Ca) channel to form a signal complex in vascular smooth muscle cells. Circ Res 104:670–678. 10.1161/circresaha.108.188748 [DOI] [PubMed] [Google Scholar]
  • 124.Lassègue B, Griendling KK (2010) NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 30:653–661. 10.1161/atvbaha.108.181610 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Ledoux J, Taylor MS, Bonev AD, Hannah RM, Solodushko V, Shui B, Tallini Y, Kotlikoff MI, Nelson MT (2008) Functional architecture of inositol 1,4,5-trisphosphate signaling in restricted spaces of myoendothelial projections. Proc Natl Acad Sci U S A 105:9627–9632. 10.1073/pnas.0801963105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.Leffler CW, Parfenova H, Jaggar JH (2011) Carbon monoxide as an endogenous vascular modulator. Am J Physiol Heart Circ Physiol 301:H1-h11. 10.1152/ajpheart.00230.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Leonoudakis D, Conti LR, Anderson S, Radeke CM, McGuire LM, Adams ME, Froehner SC, Yates JR 3rd, Vandenberg CA (2004) Protein trafficking and anchoring complexes revealed by proteomic analysis of inward rectifier potassium channel (Kir2.x)-associated proteins. J Biol Chem 279:22331–22346. 10.1074/jbc.M400285200 [DOI] [PubMed] [Google Scholar]
  • 128.Leung FP, Yung LM, Leung HS, Au CL, Yao X, Vanhoutte PM, Laher I, Huang Y (2007) Therapeutic concentrations of raloxifene augment nitric oxide-dependent coronary artery dilatation in vitro. Br J Pharmacol 152:223–229. 10.1038/sj.bjp.0707387 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Levitan I (2009) Cholesterol and Kir channels. IUBMB Life 61:781–790. 10.1002/iub.192 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Lezoualc’h F, Fazal L, Laudette M, Conte C (2016) Cyclic AMP sensor EPAC proteins and their role in cardiovascular function and disease. Circ Res 118:881–897. 10.1161/circresaha.115.306529 [DOI] [PubMed] [Google Scholar]
  • 131.Lim JE, Bernatchez P, Nabi IR (2024) Scaffolds and the scaffolding domain: an alternative paradigm for caveolin-1 signaling. Biochem Soc Trans 52:947–959. 10.1042/bst20231570 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Ling K, Men F, Wang WC, Zhou YQ, Zhang HW, Ye DW (2018) Carbon monoxide and its controlled release: therapeutic application, detection, and development of carbon monoxide releasing molecules (CORMs). J Med Chem 61:2611–2635. 10.1021/acs.jmedchem.6b01153 [DOI] [PubMed] [Google Scholar]
  • 133.Liu Y, Bubolz AH, Mendoza S, Zhang DX, Gutterman DD (2011) H2O2 is the transferrable factor mediating flow-induced dilation in human coronary arterioles. Circ Res 108:566–573. 10.1161/circresaha.110.237636 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Liu Z, Khalil RA (2018) Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease. Biochem Pharmacol 153:91–122. 10.1016/j.bcp.2018.02.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Loirand G, Guilluy C, Pacaud P (2006) Regulation of Rho proteins by phosphorylation in the cardiovascular system. Trends Cardiovasc Med 16:199–204. 10.1016/j.tcm.2006.03.010 [DOI] [PubMed] [Google Scholar]
  • 136.Longden TA, Dabertrand F, Koide M, Gonzales AL, Tykocki NR, Brayden JE, Hill-Eubanks D, Nelson MT (2017) Capillary K(+)-sensing initiates retrograde hyperpolarization to increase local cerebral blood flow. Nat Neurosci 20:717–726. 10.1038/nn.4533 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.Longden TA, Isaacs D (2025) Pericyte electrical signalling and brain haemodynamics. Basic Clin Pharmacol Toxicol 136:e70030. 10.1111/bcpt.70030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138.Longden TA, Mughal A, Hennig GW, Harraz OF, Shui B, Lee FK, Lee JC, Reining S, Kotlikoff MI, König GM, Kostenis E, Hill-Eubanks D, Nelson MT (2021) Local IP(3) receptor-mediated Ca(2+) signals compound to direct blood flow in brain capillaries. Sci Adv 7. 10.1126/sciadv.abh0101 [DOI] [PMC free article] [PubMed]
  • 139.Lu TW, Wu J, Aoto PC, Weng JH, Ahuja LG, Sun N, Cheng CY, Zhang P, Taylor SS (2019) Two PKA RIα holoenzyme states define ATP as an isoform-specific orthosteric inhibitor that competes with the allosteric activator, cAMP. Proc Natl Acad Sci U S A 116:16347–16356. 10.1073/pnas.1906036116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Ma MM, Gao M, Guo KM, Wang M, Li XY, Zeng XL, Sun L, Lv XF, Du YH, Wang GL, Zhou JG, Guan YY (2017) TMEM16A contributes to endothelial dysfunction by facilitating Nox2 NADPH oxidase-derived reactive oxygen species generation in hypertension. Hypertension 69:892–901. 10.1161/hypertensionaha.116.08874 [DOI] [PubMed] [Google Scholar]
  • 141.Ma Y, Zhang P, Li J, Lu J, Ge J, Zhao Z, Ma X, Wan S, Yao X, Shen B (2015) Epoxyeicosatrienoic acids act through TRPV4-TRPC1-KCa1.1 complex to induce smooth muscle membrane hyperpolarization and relaxation in human internal mammary arteries. Biochim Biophys Acta 1852:552–559. 10.1016/j.bbadis.2014.12.010 [DOI] [PubMed] [Google Scholar]
  • 142.MacKay CE, Leo MD, Fernández-Peña C, Hasan R, Yin W, Mata-Daboin A, Bulley S, Gammons J, Mancarella S, Jaggar JH (2020) Intravascular flow stimulates PKD2 (polycystin-2) channels in endothelial cells to reduce blood pressure. Elife 9. 10.7554/eLife.56655 [DOI] [PMC free article] [PubMed]
  • 143.Mahavadi S, Nalli A, Al-Shboul O, Murthy KS (2014) Inhibition of MLC20 phosphorylation downstream of Ca2+ and RhoA: a novel mechanism involving phosphorylation of myosin phosphatase interacting protein (M-RIP) by PKG and stimulation of MLC phosphatase activity. Cell Biochem Biophys 68:1–8. 10.1007/s12013-013-9677-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144.Manson ML, Säfholm J, Al-Ameri M, Bergman P, Orre AC, Swärd K, James A, Dahlén SE, Adner M (2014) Bitter taste receptor agonists mediate relaxation of human and rodent vascular smooth muscle. Eur J Pharmacol 740:302–311. 10.1016/j.ejphar.2014.07.005 [DOI] [PubMed] [Google Scholar]
  • 145.Mao Y, Tokudome T, Kishimoto I (2016) Ghrelin and blood pressure regulation. Curr Hypertens Rep 18:15. 10.1007/s11906-015-0622-5 [DOI] [PubMed] [Google Scholar]
  • 146.Matoba T, Shimokawa H, Kubota H, Morikawa K, Fujiki T, Kunihiro I, Mukai Y, Hirakawa Y, Takeshita A (2002) Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun 290:909–913. 10.1006/bbrc.2001.6278 [DOI] [PubMed] [Google Scholar]
  • 147.Matoba T, Shimokawa H, Morikawa K, Kubota H, Kunihiro I, Urakami-Harasawa L, Mukai Y, Hirakawa Y, Akaike T, Takeshita A (2003) Electron spin resonance detection of hydrogen peroxide as an endothelium-derived hyperpolarizing factor in porcine coronary microvessels. Arterioscler Thromb Vasc Biol 23:1224–1230. 10.1161/01.Atv.0000078601.79536.6c [DOI] [PubMed] [Google Scholar]
  • 148.Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, Takeshita A (2000) Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 106:1521–1530. 10.1172/jci10506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 149.McCarty MF (1999) Endothelial membrane potential regulates production of both nitric oxide and superoxide – a fundamental determinant of vascular health. Med Hypotheses 53:277–289. 10.1054/mehy.1998.0758 [DOI] [PubMed] [Google Scholar]
  • 150.McNeish AJ, Sandow SL, Neylon CB, Chen MX, Dora KA, Garland CJ (2006) Evidence for involvement of both IKCa and SKCa channels in hyperpolarizing responses of the rat middle cerebral artery. Stroke 37:1277–1282. 10.1161/01.Str.0000217307.71231.43 [DOI] [PubMed] [Google Scholar]
  • 151.Mederos y Schnitzler M, Storch U, Meibers S, Nurwakagari P, Breit B, Essin K, Gollasch M, Gudermann T (2008) Gq-coupled receptors as mechanosensors mediating myogenic vasoconstriction. Embo j 27:3092–3103. 10.1038/emboj.2008.233 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 152.Mendoza SA, Fang J, Gutterman DD, Wilcox DA, Bubolz AH, Li R, Suzuki M, Zhang DX (2010) TRPV4-mediated endothelial Ca2+ influx and vasodilation in response to shear stress. Am J Physiol Heart Circ Physiol 298:H466-476. 10.1152/ajpheart.00854.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153.Migkos T, Pourová J, Vopršalová M, Auger C, Schini-Kerth V, Mladěnka P (2020) Biochanin A, the most potent of 16 isoflavones, induces relaxation of the coronary artery through the calcium channel and cGMP-dependent pathway. Planta Med 86:708–716. 10.1055/a-1158-9422 [DOI] [PubMed] [Google Scholar]
  • 154.Michell BJ, Chen Z, Tiganis T, Stapleton D, Katsis F, Power DA, Sim AT, Kemp BE (2001) Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 276:17625–17628. 10.1074/jbc.C100122200 [DOI] [PubMed] [Google Scholar]
  • 155.Mironova GY, Kowalewska PM, El-Lakany M, Tran CHT, Sancho M, Zechariah A, Jackson WF, Welsh DG (2023) The conducted vasomotor response and the principles of electrical communication in resistance arteries. Physiol Rev 104:33–84. 10.1152/physrev.00035.2022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 156.Mistry DK, Garland CJ (1998) Nitric oxide (NO)-induced activation of large conductance Ca2+-dependent K+ channels (BK(Ca)) in smooth muscle cells isolated from the rat mesenteric artery. Br J Pharmacol 124:1131–1140. 10.1038/sj.bjp.0701940 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 157.Mitchell JA, Kirkby NS (2019) Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system. Br J Pharmacol 176:1038–1050. 10.1111/bph.14167 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158.Mladěnka P, Applová L, Patočka J, Costa VM, Remiao F, Pourová J, Mladěnka A, Karlíčková J, Jahodář L, Vopršalová M, Varner KJ, Štěrba M (2018) Comprehensive review of cardiovascular toxicity of drugs and related agents. Med Res Rev 38:1332–1403. 10.1002/med.21476 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 159.Montezano AC, Touyz RM (2012) Reactive oxygen species and endothelial function–role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. Basic Clin Pharmacol Toxicol 110:87–94. 10.1111/j.1742-7843.2011.00785.x [DOI] [PubMed] [Google Scholar]
  • 160.Montfort WR, Wales JA, Weichsel A (2017) Structure and activation of soluble guanylyl cyclase, the nitric oxide sensor. Antioxid Redox Signal 26:107–121. 10.1089/ars.2016.6693 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161.Moshkforoush A, Ashenagar B, Harraz OF, Dabertrand F, Longden TA, Nelson MT, Tsoukias NM (2020) The capillary Kir channel as sensor and amplifier of neuronal signals: modeling insights on K(+)-mediated neurovascular communication. Proc Natl Acad Sci U S A 117:16626–16637. 10.1073/pnas.2000151117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 162.Muniyappa R, Sowers JR (2013) Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord 14:5–12. 10.1007/s11154-012-9229-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 163.Murthy KS, Zhou H, Grider JR, Makhlouf GM (2003) Inhibition of sustained smooth muscle contraction by PKA and PKG preferentially mediated by phosphorylation of RhoA. Am J Physiol Gastrointest Liver Physiol 284:G1006-1016. 10.1152/ajpgi.00465.2002 [DOI] [PubMed] [Google Scholar]
  • 164.Najmanová I, Pourová J, Vopršalová M, Pilařová V, Semecký V, Nováková L, Mladěnka P (2016) Flavonoid metabolite 3-(3-hydroxyphenyl)propionic acid formed by human microflora decreases arterial blood pressure in rats. Mol Nutr Food Res 60:981–991. 10.1002/mnfr.201500761 [DOI] [PubMed] [Google Scholar]
  • 165.Nalli AD, Kumar DP, Al-Shboul O, Mahavadi S, Kuemmerle JF, Grider JR, Murthy KS (2014) Regulation of Gβγi-dependent PLC-β3 activity in smooth muscle: inhibitory phosphorylation of PLC-β3 by PKA and PKG and stimulatory phosphorylation of Gαi-GTPase-activating protein RGS2 by PKG. Cell Biochem Biophys 70:867–880. 10.1007/s12013-014-9992-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 166.Nelson MT, Cheng H, Rubart M, Santana LF, Bonev AD, Knot HJ, Lederer WJ (1995) Relaxation of arterial smooth muscle by calcium sparks. Science 270:633–637. 10.1126/science.270.5236.633 [DOI] [PubMed] [Google Scholar]
  • 167.Nilius B, Prenen J, Janssens A, Owsianik G, Wang C, Zhu MX, Voets T (2005) The selectivity filter of the cation channel TRPM4. J Biol Chem 280:22899–22906. 10.1074/jbc.M501686200 [DOI] [PubMed] [Google Scholar]
  • 168.Nishikawa Y, Stepp DW, Chilian WM (2000) Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am J Physiol Heart Circ Physiol 279:H459-465. 10.1152/ajpheart.2000.279.2.H459 [DOI] [PubMed] [Google Scholar]
  • 169.Nystoriak MA, Bhatnagar A (2018) Cardiovascular effects and benefits of exercise. Front Cardiovasc Med 5:135. 10.3389/fcvm.2018.00135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 170.Oak MH, Auger C, Belcastro E, Park SH, Lee HH, Schini-Kerth VB (2018) Potential mechanisms underlying cardiovascular protection by polyphenols: role of the endothelium. Free Radic Biol Med 122:161–170. 10.1016/j.freeradbiomed.2018.03.018 [DOI] [PubMed] [Google Scholar]
  • 171.Oelze M, Knorr M, Kröller-Schön S, Kossmann S, Gottschlich A, Rümmler R, Schuff A, Daub S, Doppler C, Kleinert H, Gori T, Daiber A, Münzel T (2013) Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression. Eur Heart J 34:3206–3216. 10.1093/eurheartj/ehs100 [DOI] [PubMed] [Google Scholar]
  • 172.Okahara K, Kambayashi J, Ohnishi T, Fujiwara Y, Kawasaki T, Monden M (1995) Shear stress induces expression of CNP gene in human endothelial cells. FEBS Lett 373:108–110. 10.1016/0014-5793(95)01027-c [DOI] [PubMed] [Google Scholar]
  • 173.Olesen SP, Clapham DE, Davies PF (1988) Haemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature 331:168–170. 10.1038/331168a0 [DOI] [PubMed] [Google Scholar]
  • 174.Omae T, Nagaoka T, Tanano I, Yoshida A (2013) Adiponectin-induced dilation of isolated porcine retinal arterioles via production of nitric oxide from endothelial cells. Invest Ophthalmol Vis Sci 54:4586–4594. 10.1167/iovs.13-11756 [DOI] [PubMed] [Google Scholar]
  • 175.Palao E, Slanina T, Muchová L, Šolomek T, Vítek L, Klán P (2016) Transition-metal-free CO-releasing BODIPY derivatives activatable by visible to NIR light as promising bioactive molecules. J Am Chem Soc 138:126–133. 10.1021/jacs.5b10800 [DOI] [PubMed] [Google Scholar]
  • 176.Parikh J, Kapela A, Tsoukias NM (2015) Stochastic model of endothelial TRPV4 calcium sparklets: effect of bursting and cooperativity on EDH. Biophys J 108:1566–1576. 10.1016/j.bpj.2015.01.034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 177.Park S-K, Herrnreiter A, Pfister SL, Gauthier KM, Falck BA, Falck JR, Campbell WB (2018) GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells. J Biol Chem 293:10675–10691. 10.1074/jbc.RA117.001297 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 178.Park WS, Ko JH, Kim N, Son YK, Kang SH, Warda M, Jung ID, Park YM, Han J (2007) Increased inhibition of inward rectifier K+ channels by angiotensin II in small-diameter coronary artery of isoproterenol-induced hypertrophied model. Arterioscler Thromb Vasc Biol 27:1768–1775. 10.1161/atvbaha.107.143339 [DOI] [PubMed] [Google Scholar]
  • 179.Pearson JT, Shirai M, Sukumaran V, Du CK, Tsuchimochi H, Sonobe T, Waddingham MT, Katare R, Schwenke DO (2019) Ghrelin and vascular protection Vasc Biol 1:H97-h102. 10.1530/vb-19-0024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 180.Pemberton CJ, Tokola H, Bagi Z, Koller A, Pöntinen J, Ola A, Vuolteenaho O, Szokodi I, Ruskoaho H (2004) Ghrelin induces vasoconstriction in the rat coronary vasculature without altering cardiac peptide secretion. Am J Physiol Heart Circ Physiol 287:H1522-1529. 10.1152/ajpheart.00193.2004 [DOI] [PubMed] [Google Scholar]
  • 181.Porta M, Striglia E (2020) Intravitreal anti-VEGF agents and cardiovascular risk. Intern Emerg Med 15:199–210. 10.1007/s11739-019-02253-7 [DOI] [PubMed] [Google Scholar]
  • 182.Pourová J, Najmanová I, Vopršalová M, Migkos T, Pilařová V, Applová L, Nováková L, Mladěnka P (2018) Two flavonoid metabolites, 3,4-dihydroxyphenylacetic acid and 4-methylcatechol, relax arteries ex vivo and decrease blood pressure in vivo. Vascul Pharmacol 111:36–43. 10.1016/j.vph.2018.08.008 [DOI] [PubMed] [Google Scholar]
  • 183.Presley T, Vedam K, Velayutham M, Zweier JL, Ilangovan G (2008) Activation of Hsp90-eNOS and increased NO generation attenuate respiration of hypoxia-treated endothelial cells. Am J Physiol Cell Physiol 295:C1281-1291. 10.1152/ajpcell.00550.2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 184.Pucovský V, Gordienko DV, Bolton TB (2002) Effect of nitric oxide donors and noradrenaline on Ca2+ release sites and global intracellular Ca2+ in myocytes from guinea-pig small mesenteric arteries. J Physiol 539:25–39. 10.1113/jphysiol.2001.012978 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 185.Qiao J, Huang F, Lum H (2003) PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 284:L972-980. 10.1152/ajplung.00429.2002 [DOI] [PubMed] [Google Scholar]
  • 186.Rafikov R, Fonseca FV, Kumar S, Pardo D, Darragh C, Elms S, Fulton D, Black SM (2011) eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity. J Endocrinol 210:271–284. 10.1530/joe-11-0083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 187.Ray A, Ch. Maharana K, Meenakshi S, Singh S (2023) Endothelial dysfunction and its relation in different disorders: recent update. Health Sciences Review 7:100084. 10.1016/j.hsr.2023.100084 [Google Scholar]
  • 188.Ringvold HC, Khalil RA (2017) Protein kinase C as regulator of vascular smooth muscle function and potential target in vascular disorders. Adv Pharmacol 78:203–301. 10.1016/bs.apha.2016.06.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 189.Rodrigo GC, Standen NB (2005) ATP-sensitive potassium channels. Curr Pharm Des 11:1915–1940. 10.2174/1381612054021015 [DOI] [PubMed] [Google Scholar]
  • 190.Rodríguez I, González M (2014) Physiological mechanisms of vascular response induced by shear stress and effect of exercise in systemic and placental circulation. Front Pharmacol 5:209. 10.3389/fphar.2014.00209 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 191.Rovetti R, Cui X, Garfinkel A, Weiss JN, Qu Z (2010) Spark-induced sparks as a mechanism of intracellular calcium alternans in cardiac myocytes. Circ Res 106:1582–1591. 10.1161/circresaha.109.213975 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 192.Sacerdoti D, Bolognesi M, Di Pascoli M, Gatta A, McGiff JC, Schwartzman ML, Abraham NG (2006) Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase. Am J Physiol Heart Circ Physiol 291:H1999-2002. 10.1152/ajpheart.00082.2006 [DOI] [PubMed] [Google Scholar]
  • 193.Saida K, Van Breemen C (1984) Cyclic AMP modulation of adrenoreceptor-mediated arterial smooth muscle contraction. J Gen Physiol 84:307–318. 10.1085/jgp.84.2.307 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 194.Saito H, Godo S, Sato S, Ito A, Ikumi Y, Tanaka S, Ida T, Fujii S, Akaike T, Shimokawa H (2018) Important role of endothelial caveolin-1 in the protective role of endothelium-dependent hyperpolarization against nitric oxide-mediated nitrative stress in microcirculation in mice. J Cardiovasc Pharmacol 71:113–126. 10.1097/fjc.0000000000000552 [DOI] [PubMed] [Google Scholar]
  • 195.Samelson BK, Gore BB, Whiting JL, Nygren PJ, Purkey AM, Colledge M, Langeberg LK, Dell’Acqua ML, Zweifel LS, Scott JD (2015) A-kinase anchoring protein 79/150 recruits protein kinase C to phosphorylate roundabout receptors. J Biol Chem 290:14107–14119. 10.1074/jbc.M115.637470 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 196.Sandow SL, Haddock RE, Hill CE, Chadha PS, Kerr PM, Welsh DG, Plane F (2009) What’s where and why at a vascular myoendothelial microdomain signalling complex. Clin Exp Pharmacol Physiol 36:67–76. 10.1111/j.1440-1681.2008.05076.x [DOI] [PubMed] [Google Scholar]
  • 197.Sandow SL, Hill CE (2000) Incidence of myoendothelial gap junctions in the proximal and distal mesenteric arteries of the rat is suggestive of a role in endothelium-derived hyperpolarizing factor-mediated responses. Circ Res 86:341–346. 10.1161/01.res.86.3.341 [DOI] [PubMed] [Google Scholar]
  • 198.Sandow SL, Neylon CB, Chen MX, Garland CJ (2006) Spatial separation of endothelial small- and intermediate-conductance calcium-activated potassium channels (K(Ca)) and connexins: possible relationship to vasodilator function? J Anat 209:689–698. 10.1111/j.1469-7580.2006.00647.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 199.Sancho M, Fletcher J, Welsh DG (2022) Inward rectifier potassium channels: membrane lipid-dependent mechanosensitive gates in brain vascular cells. Front Cardiovasc Med 9:869481. 10.3389/fcvm.2022.869481 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 200.Sauzeau V, Rolli-Derkinderen M, Marionneau C, Loirand G, Pacaud P (2003) RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation. J Biol Chem 278:9472–9480. 10.1074/jbc.M212776200 [DOI] [PubMed] [Google Scholar]
  • 201.Seki T, Goto K, Kiyohara K, Kansui Y, Murakami N, Haga Y, Ohtsubo T, Matsumura K, Kitazono T (2017) Downregulation of endothelial transient receptor potential vanilloid type 4 channel and small-conductance of Ca2+-activated K+ channels underpins impaired endothelium-dependent hyperpolarization in hypertension. Hypertension 69:143–153. 10.1161/hypertensionaha.116.07110 [DOI] [PubMed] [Google Scholar]
  • 202.Sellitti DF, Koles N, Mendonça MC (2011) Regulation of C-type natriuretic peptide expression. Peptides 32:1964–1971. 10.1016/j.peptides.2011.07.013 [DOI] [PubMed] [Google Scholar]
  • 203.Shimizu T, Janssens A, Voets T, Nilius B (2009) Regulation of the murine TRPP3 channel by voltage, pH, and changes in cell volume. Pflugers Arch 457:795–807. 10.1007/s00424-008-0558-6 [DOI] [PubMed] [Google Scholar]
  • 204.Shimokawa H (2010) Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pflugers Arch 459:915–922. 10.1007/s00424-010-0790-8 [DOI] [PubMed] [Google Scholar]
  • 205.Shimokawa H, Godo S (2020) Nitric oxide and endothelium-dependent hyperpolarization mediated by hydrogen peroxide in health and disease. Basic Clin Pharmacol Toxicol 127:92–101. 10.1111/bcpt.13377 [DOI] [PubMed] [Google Scholar]
  • 206.Schleifenbaum J, Kassmann M, Szijártó IA, Hercule HC, Tano JY, Weinert S, Heidenreich M, Pathan AR, Anistan YM, Alenina N, Rusch NJ, Bader M, Jentsch TJ, Gollasch M (2014) Stretch-activation of angiotensin II type 1a receptors contributes to the myogenic response of mouse mesenteric and renal arteries. Circ Res 115:263–272. 10.1161/circresaha.115.302882 [DOI] [PubMed] [Google Scholar]
  • 207.Schlossmann J, Desch M (2011) IRAG and novel PKG targeting in the cardiovascular system. Am J Physiol Heart Circ Physiol 301:H672-682. 10.1152/ajpheart.00198.2011 [DOI] [PubMed] [Google Scholar]
  • 208.Schmidt K, de Wit C (2020) Endothelium-derived hyperpolarizing factor and myoendothelial coupling: the in vivo perspective. Front Physiol 11:602930. 10.3389/fphys.2020.602930 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 209.Siegl D, Koeppen M, Wölfle SE, Pohl U, de Wit C (2005) Myoendothelial coupling is not prominent in arterioles within the mouse cremaster microcirculation in vivo. Circ Res 97:781–788. 10.1161/01.RES.0000186193.22438.6c [DOI] [PubMed] [Google Scholar]
  • 210.Smith JB (1981) Prostaglandins and platelet aggregation. Acta Med Scand Suppl 651:91–99. 10.1111/j.0954-6820.1981.tb03638.x [DOI] [PubMed] [Google Scholar]
  • 211.Sobrino A, Oviedo PJ, Novella S, Laguna-Fernandez A, Bueno C, García-Pérez MA, Tarín JJ, Cano A, Hermenegildo C (2010) Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-{alpha}. J Mol Endocrinol 44:237–246. 10.1677/jme-09-0112 [DOI] [PubMed] [Google Scholar]
  • 212.Sonkusare SK, Dalsgaard T, Bonev AD, Hill-Eubanks DC, Kotlikoff MI, Scott JD, Santana LF, Nelson MT (2014) AKAP150-dependent cooperative TRPV4 channel gating is central to endothelium-dependent vasodilation and is disrupted in hypertension. Sci Signal 7:ra66. 10.1126/scisignal.2005052 [DOI] [PMC free article] [PubMed]
  • 213.Sowa G, Pypaert M, Sessa WC (2001) Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc Natl Acad Sci U S A 98:14072–14077. 10.1073/pnas.241409998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 214.Sun J, Xin C, Eu JP, Stamler JS, Meissner G (2001) Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proc Natl Acad Sci U S A 98:11158–11162. 10.1073/pnas.201289098 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 215.Suzuki Y (2025) Ca2+ microdomains in vascular smooth muscle cells: roles in vascular tone regulation and hypertension. J Pharmacol Sci 158:59–67. 10.1016/j.jphs.2025.03.008 [DOI] [PubMed] [Google Scholar]
  • 216.Syed AU, Koide M, Brayden JE, Wellman GC (2019) Tonic regulation of middle meningeal artery diameter by ATP-sensitive potassium channels. J Cereb Blood Flow Metab 39:670–679. 10.1177/0271678x17749392 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 217.Takahashi S, Lin H, Geshi N, Mori Y, Kawarabayashi Y, Takami N, Mori MX, Honda A, Inoue R (2008) Nitric oxide-cGMP-protein kinase G pathway negatively regulates vascular transient receptor potential channel TRPC6. J Physiol 586:4209–4223. 10.1113/jphysiol.2008.156083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 218.Takai J, Santu A, Zheng H, Koh SD, Ohta M, Filimban LM, Lemaître V, Teraoka R, Jo H, Miura H (2013) Laminar shear stress upregulates endothelial Ca2⁺-activated K⁺ channels KCa2.3 and KCa3.1 via a Ca2⁺/calmodulin-dependent protein kinase kinase/Akt/p300 cascade. Am J Physiol Heart Circ Physiol 305:H484-493. 10.1152/ajpheart.00642.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 219.Talavera K, Startek JB, Alvarez-Collazo J, Boonen B, Alpizar YA, Sanchez A, Naert R, Nilius B (2020) Mammalian transient receptor potential TRPA1 channels: from structure to disease. Physiol Rev 100:725–803. 10.1152/physrev.00005.2019 [DOI] [PubMed] [Google Scholar]
  • 220.Tang EH, Vanhoutte PM (2008) Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension. Physiol Genomics 32:409–418. 10.1152/physiolgenomics.00136.2007 [DOI] [PubMed] [Google Scholar]
  • 221.Tang KM, Wang GR, Lu P, Karas RH, Aronovitz M, Heximer SP, Kaltenbronn KM, Blumer KJ, Siderovski DP, Zhu Y, Mendelsohn ME (2003) Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med 9:1506–1512. 10.1038/nm958 [DOI] [PubMed] [Google Scholar]
  • 222.Tao J, Yang Z, Wang JM, Tu C, Pan SR (2006) Effects of fluid shear stress on eNOS mRNA expression and NO production in human endothelial progenitor cells. Cardiology 106:82–88. 10.1159/000092636 [DOI] [PubMed] [Google Scholar]
  • 223.Thakore P, Earley S (2019) Transient receptor potential channels and endothelial cell calcium signaling. Compr Physiol 9:1249–1277. 10.1002/cphy.c180034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 224.Thomas DD, Liu X, Kantrow SP, Lancaster JR Jr (2001) The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. Proc Natl Acad Sci U S A 98:355–360. 10.1073/pnas.98.1.355 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 225.Thomas GR, DiFabio JM, Gori T, Parker JD (2007) Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism. J Am Coll Cardiol 49:1289–1295. 10.1016/j.jacc.2006.10.074 [DOI] [PubMed] [Google Scholar]
  • 226.Torregrosa G, Burguete MC, Pérez-Asensio FJ, Salom JB, Gil JV, Alborch E (2003) Pharmacological profile of phytoestrogens in cerebral vessels: in vitro study with rabbit basilar artery. Eur J Pharmacol 482:227–234. 10.1016/j.ejphar.2003.09.026 [DOI] [PubMed] [Google Scholar]
  • 227.Tran CH, Taylor MS, Plane F, Nagaraja S, Tsoukias NM, Solodushko V, Vigmond EJ, Furstenhaupt T, Brigdan M, Welsh DG (2012) Endothelial Ca2+ wavelets and the induction of myoendothelial feedback. Am J Physiol Cell Physiol 302:C1226-1242. 10.1152/ajpcell.00418.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 228.Triggle CR, Samuel SM, Ravishankar S, Marei I, Arunachalam G, Ding H (2012) The endothelium: influencing vascular smooth muscle in many ways. Can J Physiol Pharmacol 90:713–738. 10.1139/y2012-073 [DOI] [PubMed] [Google Scholar]
  • 229.Tsutsui M, Tanimoto A, Tamura M, Mukae H, Yanagihara N, Shimokawa H, Otsuji Y (2015) Significance of nitric oxide synthases: lessons from triple nitric oxide synthases null mice. J Pharmacol Sci 127:42–52. 10.1016/j.jphs.2014.10.002 [DOI] [PubMed] [Google Scholar]
  • 230.Tykocki NR, Boerman EM, Jackson WF (2017) Smooth muscle ion channels and regulation of vascular tone in resistance arteries and arterioles. Compr Physiol 7:485–581. 10.1002/cphy.c160011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 231.Vaandrager AB, Hogema BM, de Jonge HR (2005) Molecular properties and biological functions of cGMP-dependent protein kinase II. Front Biosci 10:2150–2164. 10.2741/1687 [DOI] [PubMed] [Google Scholar]
  • 232.van Splunder H, Villacampa P, Martínez-Romero A, Graupera M (2024) Pericytes in the disease spotlight. Trends Cell Biol 34:58–71. 10.1016/j.tcb.2023.06.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 233.Vanhoutte PM (1987) Serotonin and the vascular wall. Int J Cardiol 14:189–203. 10.1016/0167-5273(87)90008-8 [DOI] [PubMed] [Google Scholar]
  • 234.Vanhoutte PM (1991) Platelet-derived serotonin, the endothelium, and cardiovascular disease. J Cardiovasc Pharmacol 17(Suppl 5):S6-12 [PubMed] [Google Scholar]
  • 235.Vanhoutte PM, Shimokawa H, Feletou M, Tang EH (2017) Endothelial dysfunction and vascular disease - a 30th anniversary update. Acta Physiol (Oxf) 219:22–96. 10.1111/apha.12646 [DOI] [PubMed] [Google Scholar]
  • 236.VanSchouwen B, Selvaratnam R, Giri R, Lorenz R, Herberg FW, Kim C, Melacini G (2015) Mechanism of cAMP partial agonism in protein kinase G (PKG). J Biol Chem 290:28631–28641. 10.1074/jbc.M115.685305 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 237.Vennekens R, Hoenderop JG, Prenen J, Stuiver M, Willems PH, Droogmans G, Nilius B, Bindels RJ (2000) Permeation and gating properties of the novel epithelial Ca(2+) channel. J Biol Chem 275:3963–3969. 10.1074/jbc.275.6.3963 [DOI] [PubMed] [Google Scholar]
  • 238.Wang H, Wang AX, Aylor K, Barrett EJ (2013) Nitric oxide directly promotes vascular endothelial insulin transport. Diabetes 62:4030–4042. 10.2337/db13-0627 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 239.Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B (2003) Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 424:434–438. 10.1038/nature01807 [DOI] [PubMed] [Google Scholar]
  • 240.Westcott EB, Jackson WF (2011) Heterogeneous function of ryanodine receptors, but not IP3 receptors, in hamster cremaster muscle feed arteries and arterioles. Am J Physiol Heart Circ Physiol 300:H1616-1630. 10.1152/ajpheart.00728.2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 241.Weston AH, Porter EL, Harno E, Edwards G (2010) Impairment of endothelial SK(Ca) channels and of downstream hyperpolarizing pathways in mesenteric arteries from spontaneously hypertensive rats. Br J Pharmacol 160:836–843. 10.1111/j.1476-5381.2010.00657.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 242.Widmann MD, Weintraub NL, Fudge JL, Brooks LA, Dellsperger KC (1998) Cytochrome P-450 pathway in acetylcholine-induced canine coronary microvascular vasodilation in vivo. Am J Physiol 274:H283-289. 10.1152/ajpheart.1998.274.1.H283 [DOI] [PubMed] [Google Scholar]
  • 243.Wilson C, Lee MD, McCarron JG (2016) Acetylcholine released by endothelial cells facilitates flow-mediated dilatation. J Physiol 594:7267–7307. 10.1113/jp272927 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 244.Wong CM, Yao X, Au CL, Tsang SY, Fung KP, Laher I, Vanhoutte PM, Huang Y (2006) Raloxifene prevents endothelial dysfunction in aging ovariectomized female rats. Vascul Pharmacol 44:290–298. 10.1016/j.vph.2005.12.005 [DOI] [PubMed] [Google Scholar]
  • 245.Woodman CR, Price EM (1985) Laughlin MH (2005) Shear stress induces eNOS mRNA expression and improves endothelium-dependent dilation in senescent soleus muscle feed arteries. J Appl Physiol 98:940–946. 10.1152/japplphysiol.00408.2004 [DOI] [PubMed] [Google Scholar]
  • 246.Wu D, Hu Q, Zhu D (2018) An update on hydrogen sulfide and nitric oxide interactions in the cardiovascular system. Oxid Med Cell Longev 2018:4579140. 10.1155/2018/4579140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 247.Wu Q, Finley SD (2020) Mathematical model predicts effective strategies to inhibit VEGF-eNOS signaling. J Clin Med 9. 10.3390/jcm9051255 [DOI] [PMC free article] [PubMed]
  • 248.Wu Y, Fu J, Huang Y, Duan R, Zhang W, Wang C, Wang S, Hu X, Zhao H, Wang L, Liu J, Gao G, Yuan P (2023) Biology and function of pericytes in the vascular microcirculation. Animal Model Exp Med 6:337–345. 10.1002/ame2.12334 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 249.Yada T, Shimokawa H, Hiramatsu O, Haruna Y, Morita Y, Kashihara N, Shinozaki Y, Mori H, Goto M, Ogasawara Y, Kajiya F (2006) Cardioprotective role of endogenous hydrogen peroxide during ischemia-reperfusion injury in canine coronary microcirculation in vivo. Am J Physiol Heart Circ Physiol 291:H1138-1146. 10.1152/ajpheart.00187.2006 [DOI] [PubMed] [Google Scholar]
  • 250.Yang G, Wang R (2015) H2S and blood vessels: an overview. Handb Exp Pharmacol 230:85–110. 10.1007/978-3-319-18144-8_4 [DOI] [PubMed] [Google Scholar]
  • 251.Yang JX, Lin Y (2005) The action of PKA on smooth muscle myosin phosphorylation. Life Sci 77:2669–2675. 10.1016/j.lfs.2005.04.026 [DOI] [PubMed] [Google Scholar]
  • 252.Yang T, Du Y (2012) Distinct roles of central and peripheral prostaglandin E2 and EP subtypes in blood pressure regulation. Am J Hypertens 25:1042–1049. 10.1038/ajh.2012.67 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 253.Yao L, Romero MJ, Toque HA, Yang G, Caldwell RB, Caldwell RW (2010) The role of RhoA/Rho kinase pathway in endothelial dysfunction. J Cardiovasc Dis Res 1:165–170. 10.4103/0975-3583.74258 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 254.Ye D, Zhou W, Lee HC (2005) Activation of rat mesenteric arterial KATP channels by 11,12-epoxyeicosatrienoic acid. Am J Physiol Heart Circ Physiol 288:H358-364. 10.1152/ajpheart.00423.2004 [DOI] [PubMed] [Google Scholar]
  • 255.Ye D, Zhou W, Lu T, Jagadeesh SG, Falck JR, Lee HC (2006) Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid. Am J Physiol Heart Circ Physiol 290:H1326-1336. 10.1152/ajpheart.00318.2005 [DOI] [PubMed] [Google Scholar]
  • 256.Yu X, Li F, Klussmann E, Stallone JN, Han G (2014) G protein-coupled estrogen receptor 1 mediates relaxation of coronary arteries via cAMP/PKA-dependent activation of MLCP. Am J Physiol Endocrinol Metab 307:E398-407. 10.1152/ajpendo.00534.2013 [DOI] [PubMed] [Google Scholar]
  • 257.Zakeri R, Levine JA, Koepp GA, Borlaug BA, Chirinos JA, LeWinter M, VanBuren P, Dávila-Román VG, de Las FL, Khazanie P, Hernandez A, Anstrom K, Redfield MM (2015) Nitrate’s effect on activity tolerance in heart failure with preserved ejection fraction trial: rationale and design. Circ Heart Fail 8:221–228. 10.1161/circheartfailure.114.001598 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 258.Zhang DX, Borbouse L, Gebremedhin D, Mendoza SA, Zinkevich NS, Li R, Gutterman DD (2012) H2O2-induced dilation in human coronary arterioles: role of protein kinase G dimerization and large-conductance Ca2+-activated K+ channel activation. Circ Res 110:471–480. 10.1161/circresaha.111.258871 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 259.Zhao G, Neeb ZP, Leo MD, Pachuau J, Adebiyi A, Ouyang K, Chen J, Jaggar JH (2010) Type 1 IP3 receptors activate BKCa channels via local molecular coupling in arterial smooth muscle cells. J Gen Physiol 136:283–291. 10.1085/jgp.201010453 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 260.Zhao Y, Pacheco A, Xian M (2015) Medicinal chemistry: insights into the development of novel H2S donors. Handb Exp Pharmacol 230:365–388. 10.1007/978-3-319-18144-8_18 [DOI] [PubMed] [Google Scholar]
  • 261.Zheng YZ, Boscher C, Inder KL, Fairbank M, Loo D, Hill MM, Nabi IR, Foster LJ (2011) Differential impact of caveolae and caveolin-1 scaffolds on the membrane raft proteome. Mol Cell Proteomics 10(M110):007146. 10.1074/mcp.M110.007146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 262.ZhuGe R, Sims SM, Tuft RA, Fogarty KE, Walsh JV Jr (1998) Ca2+ sparks activate K+ and Cl- channels, resulting in spontaneous transient currents in guinea-pig tracheal myocytes. J Physiol 513(Pt 3):711–718. 10.1111/j.1469-7793.1998.711ba.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 263.Zoccali C, Curatola G, Panuccio V, Tripepi R, Pizzini P, Versace M, Bolignano D, Cutrupi S, Politi R, Tripepi G, Ghiadoni L, Thadhani R, Mallamaci F (2014) Paricalcitol and endothelial function in chronic kidney disease trial. Hypertension 64:1005–1011. 10.1161/hypertensionaha.114.03748 [DOI] [PubMed] [Google Scholar]
  • 264.Zou Q, Leung SW, Vanhoutte PM (2015) Transient receptor potential channel opening releases endogenous acetylcholine, which contributes to endothelium-dependent relaxation induced by mild hypothermia in spontaneously hypertensive rat but not Wistar-Kyoto rat arteries. J Pharmacol Exp Ther 354:121–130. 10.1124/jpet.115.223693 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

No datasets were generated or analysed during the current study.


Articles from Pflugers Archiv are provided here courtesy of Springer

RESOURCES